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ABSTRACT  
Metabolic engineering is an extremely useful tool enabling the biosynthetic 
production of commodity chemicals (typically derived from petroleum) from renewable 
resources. In this work, a pathway for the biosynthesis of styrene (a plastics monomer) 
has been engineered in Escherichia coli from glucose by utilizing the pathway for the 
naturally occurring amino acid phenylalanine, the precursor to styrene. Styrene 
production was accomplished using an E. coli phenylalanine overproducer, E. coli 
NST74, and over-expression of PAL2 from Arabidopsis thaliana and FDC1 from 
Saccharomyces cerevisiae. The styrene pathway was then extended by just one enzyme 
to either (S)-styrene oxide (StyAB from Pseudomonas putida S12) or (R)-1,2-
phenylethanediol (NahAaAbAcAd from Pseudomonas sp. NCIB 9816-4) which are both 
used in pharmaceutical production. Overall, these pathways suffered from limitations due 
to product toxicity as well as limited precursor availability. In an effort to overcome the 
toxicity threshold, the styrene pathway was transferred to a yeast host with a higher 
toxicity limit. First, Saccharomyces cerevisiae BY4741 was engineered to overproduce 
phenylalanine. Next, PAL2 (the only enzyme needed to complete the styrene pathway) 
was then expressed in the BY4741 phenylalanine overproducer. Further strain 
improvements included the deletion of the phenylpyruvate decarboxylase (ARO10) and 
expression of a feedback-resistant choristmate mutase (ARO4
K229L
). These works have 
successfully demonstrated the possibility of utilizing microorganisms as cellular factories 
for the production styrene, (S)-styrene oxide, and (R)-1,2-phenylethanediol. 
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CHAPTER 1 
INTRODUCTION 
Abstract 
This chapter describes background information on the field of metabolic 
engineering and the motivation for my project on the construction of pathways from L-
phenylalanine. The metabolic pathway for styrene and its derivatives (S)-styrene oxide 
and (R)-1,2-phenylethanediol will be provided. This chapter concludes with the 
dissertation organization. 
1.1 Background and motivation 
A demand for commodity chemicals by renewable means rather than fossil fuels 
has been increasing in recent years. Microorganisms are capable of naturally producing 
various useful products including pharmaceuticals, fuels, and polymers; however, often at 
too small of quantities for industrial economic viability. Metabolic engineering enables 
efficient construction of both high yield pathways that already exist in nature and novel 
pathways that may be constructed from the enzymatic parts of various microorganisms. 
Utilizing a diversity of enzymes through the tools of metabolic engineering, researchers 
have successfully catalyzed a wide array of biochemical reactions producing important 
biofuels, pharmaceuticals, and other fine chemicals.  
 The most prominent application of metabolic engineering is currently in the 
transportation fuel sector with a heavy focus on bio-ethanol and bio-butanol production. 
Though these biofuels represent the highest volume of biologically produced chemicals, 
they also have the lowest profit margin due to the discrepancy between the high cost of 
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processing suitable carbon substrates (sugars such as glucose) and the value of the final 
product (Keasling 2010). While the biofuels sector has been of primary interest for the 
last several decades, recent interest in utilizing metabolic engineering for the production 
of pharmaceuticals and fine chemicals has developed. Not only does a biosynthetic route 
offer a renewable means of producing commodity chemicals, it also gives us the ability to 
circumvent the high energetic requirements of chemocatalytic production (as is the case 
of styrene from ethylbenzene), control the stereospecificity of chiral compounds (a 
necessity for pharmaceutical precursors), as well as manufacture compounds which can 
only be produced naturally (such as amino acids, vitamins, flavors, and fragrances). 
Several examples of fine chemicals synthesized from microbial platforms have recently 
been reported, most notably monomers of polymers and co-polymers such as 1,5-
diaminopentane and 1,4-diaminopentane (Qian, Xia, and Lee 2011) (used to make 
polyamids like Nylon) as well as isoprene (Lindberg, Park, and Melis 2010) (a monomer 
for rubber and copolymer synthesis). Since these products are indistinguishable from 
those of petrochemical origin, no change in industry infrastructure is necessary for their 
incorporation into existing polymer and co-polymer synthesis methods. Thus, metabolic 
engineering strategies provide new opportunities to develop products of commercial 
interest by biosynthetic means thereby reducing our dependence on nonrenewable 
resources and offering a ‘green chemistry’ approach to producing essential commodity 
chemicals. 
Monoaromatic compounds are an important and diverse class of fine chemicals 
with applications ranging from use as solvents to monomers for polymer synthesis. 
Several monoaromatic compounds have been microbially synthesized to date, but the 
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origin of these compounds have been mainly derived from p-coumarate via the L-tyrosine 
pathway, making them phenolics(Boudet 2007). This approach simply replicates the 
natural pathways commonly found in plants. In natural systems, phenolics play vital roles 
in plant physiology and fitness. For example, plants produce phenolic polymers, like 
lignin and suberin, as structural components of their cellular wall, as well as flavanoids 
for pigmentation which is used to attract pollinators and as UV filtration(Boudet 2007). 
With such an apparent necessity for phenolics in natural systems, there exists a plethora 
of enzymes and enzymatic sources for phenolic based reactions. Examples of phenolics 
which have been heterologously synthesized include phenol (a monomer for phenolic 
resins)(Wierckx et al. 2005), p-hydroxybenzoate (a precursor to parabens)(Verhoef et al. 
2007), caffeate (an antioxidant and antitumor agent)(Zhang and Stephanopoulos 2012), 
tyrosol (an antioxidant)(Satoh et al. 2012), and p-hydroxystyrene  (a useful 
copolymer)(Qi et al. 2007; Verhoef et al. 2009). However, the number of biosynthesized 
non-phenolic monoaromatics remains limited to-date. This, in part, is due to the fact that 
non-phenolics are relatively uncommon in natural systems; therefore, pathway design is 
more difficult and requires novel approaches. In addition, the pool of known enzymes 
which express activity on non-phenolics is also greatly limited. Enzymes which 
demonstrate activity on phenolics often utilize the para-hydroxyl group of the substrate 
for stability serving as a hydrogen bond donor or acceptor(Brownlee et al. 2008; Serre et 
al. 1999; Caruso et al. 2004; Rodríguez et al. 2010). Due to the necessity of the para-
hydroxyl group, these phenolic enzymes often possess limited, if any, substrate 
promiscuity thereby limiting their potential use on non-phenolic homologues.  
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As previously mentioned, the number of non-phenolic monoaromatic compounds 
engineered from renewable resources remains limited, and thus the focus of this work 
will be on the biosynthetic production of monoaromatics derived via phenylalanine, 
namely styrene and its derivatives, (S)-styrene oxide and (R)-1,2-phenylethanediol. 
Styrene is a high-value monomer used in the production of polymers and copolymers, 
most notably polystyrene, acrylonitrile-butadiene-styrene (ABS), styrene-acrylonitrile 
(SAN), and styrene-butadiene rubber. As one of the most important monomers in the 
plastics industry, its annual production exceeds 6 million metric tons per year 
representing a $28 billion market(McKenna and Nielsen 2011). However, while its uses 
and need by consumers is apparent, production of styrene via the dehydrogenation of 
petroleum-derived ethylbenzene is also one of the most energy intensive processes 
requiring 3 metric tons of steam per metric ton of styrene produced(McKenna and 
Nielsen 2011). Not only is styrene an essential and valuable precursor to plastics, it is 
also an important precursor to the fine chemicals (S)-styrene oxide and (R)-1,2-
phenylethanediol. These styrene derivatives are chiral building blocks used for the 
production of pharmaceuticals as well as other compounds of interest. For example, (S)-
Styrene oxide is used as a precursor to the biocides levamisole and nematocide(Park, So, 
et al. 2006) as well as the synthesis of cosmetics(Loprieno et al. 1976), surface coatings, 
and agricultural(Loprieno et al. 1976) and biological(Panke et al. 2000; Han et al. 2006) 
chemicals. (R)-1,2-Phenylethanediol is used in the synthesis of the pharmaceuticals (R)-
norfluoxetine and (R)-fluoxetine, which are used to treat psychiatric and metabolic 
disorders, as well as β-lactam antibiotics(Cao et al. 2006; Kumar, Upadhyay, and Pandey 
2004). Additionally, (R)-1,2-phenylethanediol is also used in the production of various 
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agrochemicals and pheromones(Gamenara and Dominguez de Maria 2009). In the face of 
rising costs of oil, alternative, renewable production methods for these compounds will 
secure the future accessibility to meet the needs of consumers.    
1.2 Metabolic pathways 
Phenylalanine, the necessary endogenous precursor to the production of styrenics, 
is produced via the shikimic acid pathway in addition to tyrosine and tryptophan as seen 
in Fig. 1.1. However, in E. coli, the aromatic amino acids are used only for the production 
of proteins and not as precursors for secondary metabolites; therefore, the pathway is 
tightly feedback-regulated. The shikimic acid pathway begins with the condensation of 
phosphoenolpyruvate (PEP), a key intermediate in glycolysis, and erythrose-4-phosphate 
(E-4P), a key intermediate in the pentose phosphate pathway, to yield the first major 
precursor of the pathway, 3-deoxy-D-arbino-heptulosonate-7-phosphate (DAHP). This 
reaction is achieved via the DAHP synthase enzymes AroF, AroG, and AroH which are 
feedback sensitive to tyrosine, phenylalanine, and tryptophan, respectively. The 
regulation of these enzymes is two-fold, including regulation at the transcriptional level 
as well as at the protein level. Firstly, to control transcription, the aromatic amino acids 
form a complex with their DNA-binding transcriptional regulator (TyrR for 
phenylalanine and tyrosine, TrpR for tryptophan) which then binds to a palindromic 
target sequence near the transcriptional promoter region of the genes aroF, aroG, and 
aroH. The presence of the DNA-binding protein complex interferes with the proper 
binding of RNA polymerase and thereby inhibits transcription from occurring. Secondly, 
the proteins themselves are regulated via allosteric enzyme inhibition. Upon binding of 
the aromatic amino acids to their respective feedback-sensitive DAHP synthase, a 
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conformational change of the enzyme occurs which represses its activity further. In 
addition to feedback control of DAHP synthase activity, the shikimic acid pathway is also 
tight regulated at the metabolite chorismate, which is a key branch point for the three 
aromatic amino acids. To produce phenylalanine, chorismate is converted to prephenate 
and subsequently to phenylpyruvate via the bifunctional chorismate mutase/prephenate 
dehydratase enzyme PheA. However, unlike the DAHP synthases, PheA is only regulated 
via allosteric enzyme inhibition and is not regulated transcriptionally(Keseler et al. 2005). 
To achieve high flux through the shikimic acid pathway and obtain high titers of 
phenylalanine, it is necessary to relieve the feedback regulation imposed on the key 
enzymes in E. coli.   
A feedback resistant strain of E. coli, NST74 (ATCC 31884), has been previously 
engineered to overproduce phenylalanine(Tribe 1987). This was accomplished via NTG 
(N-methyl-N'-nitro-N-nitrosoguanidine) mutagenesis and subsequent selection of mutants 
in minimal media containing the phenylalanine anti-metabolites β-2-thienylalanine or p-
fluoro-DL-phenylalanine. In the presence of phenylalanine anti-metabolites, feedback 
regulation of the shikimic acid pathway is activated and natural production of 
phenylalanine ceases. In order to survive in the presence of the anti-metabolites, the 
strain must evolve to de-regulate the feedback sensitive enzymes. This approach resulted 
in the development of the strain E. coli NST74 with the relevant genotype aroH367(fbr), 
tyrR366, tna-2, lacY5, aroF394(fbr), malT384, pheA101(fbr), pheO352, aroG397(fbr). 
As described, E.coli NST74 possesses mutations which relieve the allosteric enzyme 
inhibition of the DAHP synthase enzymes AroF, AroG, and AroH as well as the 
chorismate mutase/prephenate dehydratase PheA. In addition, the DNA-binding 
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transcriptional regulator TyrR and the phenylalanine operator pheO has also been 
mutated to alleviate repression. As a result of these key mutations, phenylalanine titers as 
high as 1.98 g/L were achieved in 1 L bioreactor experiments(Tribe 1987). E. coli 
NST74's ability to produce copious amounts of phenylalanine makes it an ideal host 
platform for the biosynthetic production of the non-natural, monoaromatics styrene, (S)-
styrene oxide, and (R)-1,2-phenylethanediol.  
The proposed biosynthesis of styrene and its derivatives (S)-styrene oxide and 
(R)-1,2-phenylethanediol may be achieved from endogenously produced phenylalanine, 
as illustrated in Fig. 1.1. Firstly, phenylalanine is deaminated to trans-cinnamate via the 
expression of a suitable phenylalanine ammonia lyase (PAL). Secondly, trans-cinnamate 
is decarboxylated to styrene via the expression of a suitable phenylacrylate decarboxylase 
(PADC). To date, the only known PADC which demonstrates activity toward styrene is 
the ferulate decarboxylase (FDC1) of Saccharomyces cerevisiae. Styrene may then be 
oxidized to (S)-styrene oxide via the expression of a styrene monooxygenase, namely 
StyAB from Pseudomonas putida S12, or (R)-1,2-phenylethanediol via the expression of 
a naphthalene dioxygenase which demonstrates activity on styrene, namely 
NahAaAbAcAd from Pseudomonas NCIB 9816. In each enzymatic step of the described 
pathway, various enzymes were tested for their activity and specificity, which will be 
discussed in further detail in the proceeding chapters.     
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Figure 1.1. Enzymatic pathway to convert glucose to styrene, (S)-styrene oxide and 
(R)-1,2-phenylethanediol via the shikimic acid pathway through the native 
metabolite L-phenylalanine. Multiple arrows signify that multiple steps are occurring 
but are not illustrated. Dotted lines from the aromatic amino acids indicate feedback-
repression via transcriptional regulation or allosteric enzyme inhibition, or both. 
Metabolite and gene abbreviations(Keseler et al. 2005; Krieger et al. 2004): 
phosphoenolpyruvate (PEP), D-erythrose-4-phosphate (E-4P), 3-deoxy-D-arabino-
heptulosonate-7-phosphate (DAHP), 2-dehydro-3-deoxyphosphoheptonate aldolase 
(aroF, aroG, aroH), chorismate muatse/prephenate dehydratase (pheA), phenylalanine 
ammonia lyase (PAL), ferulate decarboxylase (FDC1), styrene monooxygenase (StyAB), 
and naphthalene dioxygenase (NahAaAbAcAd).     
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1.3 Dissertation organization 
 This dissertation is organized into five chapters. Chapter 1 discusses a background 
into the field of metabolic engineering and the importance of determining methods to 
create fine chemicals such as styrene, (S)-styrene oxide, and (R)-1,2-phenylethanediol 
from renewable resources. This chapter also gives an outline of the metabolic pathways 
constructed during this project as well as an overview of E. coli’s phenylalanine pathway. 
Chapter 2 introduces us to pathway engineering through the development of a renewable 
method for the biosynthesis of styrene in E. coli. This is the first example of a renewable 
method for styrene production from renewable resources such as glucose. This chapter 
will show that the styrene monomer is extremely toxic to the bacteria and severely limits 
production titers. The styrene pathway is then extended to (S)-styrene oxide and (R)-1,2-
phenylethanediol in Chapter 3. When the endogenously produced styrene is converted to 
these less toxic compounds, higher productivities are achieved. However, at this point the 
pathway is limited not only by toxicity but by the ability to make ample amounts of the 
endogenous precursor phenylalanine. Several methods to improve phenylalanine titers 
will be discussed. Since the main difficulty in biosynthetically producing monoaromatics 
in E. coli remains the toxicity threshold, Chapter 4, focuses on transferring the styrene 
pathway to a new yeast host. The work encompasses using S. cerevisiae which will be 
engineered to overproduce phenylalanine. The styrene pathway was incorporated into the 
S. cerevisiae phenylalanine over-producer and tested for styrene production from glucose. 
Chapter 5 will suggest future directions for the styrene pathway and its derivatives. 
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CHAPTER 2 
BIOSYNTHESIS OF STYRENE BY ENGINEERED E. COLI 
Abstract 
Styrene is a large volume, commodity petrochemical with diverse commercial 
applications, including as a monomer building-block for the synthesis of many useful 
polymers. Here we demonstrate how, through the de novo design and development of a 
novel metabolic pathway, styrene can alternatively be synthesized from renewable 
substrates such as glucose. The conversion of endogenously-synthesized L-phenylalanine 
to styrene was achieved by the co-expression of phenylalanine ammonia lyase and trans-
cinnamate decarboxylase. Candidate isoenzymes for each step were screened from 
bacterial, yeast, and plant genetic sources. Finally, over-expression of PAL2 from A. 
thaliana and FDC1 from S. cerevisiae (originally classified as ferulate decarboxylase) in 
an L-phenylalanine over-producing E. coli host led to the accumulation of up to 260 
mg/L in shake flask cultures.  Achievable titers already approach the styrene toxicity 
threshold (determined as ~300 mg/L). To the best of our knowledge, this is the first 
report of microbial styrene production from sustainable feedstocks.  
 
This work was published as:  
McKenna, R. & Nielsen, D.R. Styrene biosynthesis from glucose by engineered E. coli. 
Metab Eng 13, 544-554 (2011) 
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2.1 Introduction 
Styrene is a versatile, large commodity chemical for which 60% of its global 
annual consumption supports the production of numerous, industrially-important 
polymers and co-polymers(SRI 2010). In 2006, over 6 million metric tons of styrene 
were produced by U.S. manufacturers, a market that was valued at nearly $28 billion and 
projected to grow by 4.3% per year through 2010(SRI 2010). Today, all commercially-
available styrene is derived from the world’s dwindling petroleum resources. 
Conventional styrene synthesis is achieved through the chemocatalytic dehydrogenation 
of petroleum-derived ethylbenzene(Wu, Koylinski, and Bozik 1981) which requires over 
3 metric tons of steam per metric ton of styrene produced. This exorbitant requirement 
renders styrene production as the most energy-intensive among commodity chemical 
production routes, consuming nearly 200 trillion BTU of steam for its domestic annual 
production alone (DoE 2002).  With that being said, the goal of this study was to engineer 
a biocatalyst capable of synthesizing styrene from renewable resources as a more 
sustainable and greener source of styrene and styrene-derived polymers.    
Beyond its petrochemical origins, styrene has been observed as a trace metabolite 
in foods, in particular cheeses, where it acts as an aroma defect. For instance, the yeast 
Penicillium camemberti has been reported to be capable of synthesizing low levels of 
styrene from excess L-phenylalanine, but neither a defined pathway nor the requisite 
genes have thus far been elucidated(Pagot et al. 2007). Styrene is also known to be 
naturally synthesized by select plant species, including several trees in the Styracaceae 
family (including several Styrax sp.). Here, styrene is also synthesized from excess L-
phenylalanine where it then subsequently accumulates as a minor constituent (<0.55% of 
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total dry weight) within benzoin resins (which are predominantly composed of benzoic 
acid)(Fernandez et al. 2005).  Again, however, neither the enzymes nor genes associated 
with said pathway have been identified to date. Although it is possible to purify styrene 
from plant resins via distillation or liquid-liquid extraction(Clark 1990), considering the 
extremely low productivity, poor net yields, and low inherent value of styrene, its 
potential, large-scale biological production by such a mechanism is rendered as 
completely uneconomical and unsustainable. A more sustainable and inexpensive 
approach, however, would involve the engineering of microorganisms that possess the 
unique ability to synthesize styrene directly from renewable resources. 
In recent years, a variety of additional, novel synthetic routes have been proposed 
and engineered in microorganisms for the production (from renewable substrates such as 
glucose) of a number of other useful, functionalized monoaromatic compounds with 
structural similarity to styrene. For example, a biosynthetic pathway for the production of 
p-hydroxystyrene (a monomer used in synthesis of photo-resist polymers) from 
renewable sugars has been constructed using both Escherichia coli(Qi et al. 2007) and 
Pseudomonas putida(Verhoef et al. 2009) as host platforms. Meanwhile, both phenol (a 
precursor and monomer for phenolic resins)(Wierckx et al. 2005) and p-hydroxybenzoate 
(a precursor to parabens, which are used as preservatives)(Verhoef et al. 2007) have also 
been synthesized as individual products from glucose by engineered strains of P. putida. 
Interestingly, each of the above non-natural metabolites were derived using L-tyrosine (or 
its immediate precursor, 4-hydroxyphenylpyruvate) as a pathway precursor, thereby 
making them each phenolics(Boudet 2007). To date, there remain few examples of 
engineered biosynthetic pathways for the production of non-phenolic, monoaromatic 
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compounds using microbial biocatalysts.  Moreover, there exist no previous reports 
regarding the development of a styrene biosynthetic pathway or the engineering of 
microbes capable of synthesizing styrene from renewable resources. With this in mind, 
the present study describes the de novo design and development of a functional styrene 
biosynthetic pathway and the engineering of E. coli strains capable of styrene 
biosynthesis from glucose. 
 The proposed styrene biosynthesis pathway utilizes endogenously synthesized 
(from glucose) L-phenylalanine as an intermediate precursor which is converted to 
styrene by a series of two enzymatic steps, as in Fig. 2.1. First, endogenously-occurring 
L-phenylalanine is converted to trans-cinnamic acid (tCA) through its deamination, as 
catalyzed by phenylalanine ammonia lyase (PAL). Said activity and substrate specificity 
has been previously reported for a number of PAL isoenzymes that have been identified 
and characterized in yeast(Vannelli, Xue, et al. 2007; Qi et al. 2007; Gilbert and Tully 
1982), plants(Young, Towers, and Neish 1966; Cochrane, Davin, and Lewis 2004), and 
(although less prevalently) bacteria(Moffitt et al. 2007; Xiang and Moore 2005, 2006; 
Young, Towers, and Neish 1966). Among previously characterized PAL isoenzymes, 
considerable variability with respect to both substrate specificity and activity has been 
reported. The most commonly studied PAL isoenzyme in recombinant systems, including 
E. coli, remains the bifunctional PAL/TAL (TAL: tyrosine ammonia lyase, which also 
catalyzes the deamination of L-tyrosine to p-coumaric acid) of the yeast Rhodotorula 
sp.(Gilbert et al. 1985; Gilbert and Tully 1982; Gilbert, Stephenson, and Tully 1983; Cui, 
Jia, and Sun 2008; Vannelli, Wei Qi, et al. 2007; Santos, Koffas, and Stephanopoulos 
2011).  Meanwhile, a number of PAL isoenzymes have been also been studied from plant 
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sources(Jones 1984) where, for example, Arabidopsis thaliana has been characterized as 
possessing four distinct PALs (encoded by PAL1, PAL2, PAL3, and PAL4)(Cochrane, 
Davin, and Lewis 2004). More recently, a number of prokaryotic PALs have been 
isolated and characterized, beginning with that which is encoded by encP from 
Streptomyces maritimus(Xiang and Moore 2002, 2005). Soon after, two additional PAL 
isoenzymes were discovered in the cyanobacteria Nostoc puntiformes and Anabaena 
variabilis(Moffitt et al. 2007; Xiang and Moore 2005, 2006). Interestingly, each of these 
prokaryotic PALs was also found to be highly specific for L-phenylalanine, and thus do 
not also display TAL activity that is so common among yeast PALs.   
 
Figure 2.1 Styrene pathway. Enzymatic pathway to convert the precursor L-
phenylalanine to the product styrene via the intermediate trans-cinnamate.  The two-step 
pathway from L-phenylalanine is achieved by the co-expression of one or more genes 
which encoded phenylalanine ammonia lyase (PAL) activity (A), and one or more genes 
which encoded trans-cinnamic acid decarboxylase (CADC) activity (B).  
 
The second step in the proposed styrene biosynthesis pathway involves the 
subsequent decarboxylation of tCA by a phenylacrylate decarboxylase (PADC) 
displaying trans-cinnamate decarboxylase activity to yield styrene as the final product. 
Several genes encoding PADC activity have been characterized and reported in the 
literature, including pdc from Lactobacillus plantarum and padC from Bacillus 
subtilis(Tran et al. 2008). It currently remains unknown, however, if their enzyme 
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products could specifically decarboxylate tCA to produce styrene. Meanwhile, the yeast 
Saccharomyces cerevisiae has demonstrated the ability to synthesize styrene when 
supplied with exogenous tCA(Clausen et al. 1994); however, the underlying mechanism 
and genetic basis for said activity presently remains unclear. For instance, previous 
characterizations of PAD1 have shown that its over-expression in S. cerevisiae results in 
increased resistance to tCA (as achieved by its conversion to styrene)(Larsson, 
Nilvebrant, and Jonsson 2001).  However, it has also been demonstrated that the 
expression of PAD1 alone is insufficient for achieving PADC activity(Clausen et al. 
1994), and it was later speculated that the expression of a second enzyme was necessary 
to convert tCA to styrene(Jiang, Wood, and Morgan 2005). Most recently, it was reported 
that tCA decarboxylase activity in S. cerevisiae maintains an essential dependence on the 
co-expression of both PAD1 and FDC1, the latter a gene previously characterized as 
encoding ferulic acid decarboxylase (note that ferulic acid is also a phenylacrylic 
acid)(Mukai et al. 2010).  
 The present study describes the de novo design of a styrene biosynthetic pathway, 
as supported through the comprehensive screening of composite pathways enzymes from 
various genetic sources. The synthesis of styrene from glucose was ultimately achieved 
through the co-expression of PAL and tCA decarboxylase enzymes in an L-phenylalanine 
over-producing E. coli host platform. 
2.2 Materials and Methods 
2.2.1 Chemicals.   
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Chemicals used in this study include L-phenylalanine (98.5%, VWR, 
Westchester, PA), trans-cinnamic acid (99%, MP Biomedicals, Solon, OH), styrene 
(99%, Alfa Aesar, Ward Hill, MA), methanol (99.8%, VWR, Westchester, PA), and 
trifluoroacetic acid (99.5%, EMD, Darmstadt, Germany). All other chemicals used in this 
study are from Sigma-Aldrich (St. Louis, MO). 
2.2.2 Strains and Media.   
All strains, plasmids, and oligonucleotide primers used in this study are listed in 
Table 2.1. Custom oligonucleotide primers were synthesized by Integrated DNA 
Technologies (Coralville, IA).  cDNA of N. puntiformes and A. variabilis were gifts from 
Prof. Bradley Moore (UCSD). Strains of B. subtilis, L. plantarum, and S. cerevisiae, as 
well as the plasmids pSTV28 and pTrc99A were all gifts from Prof. Kristala Prather 
(MIT). Genomic DNA was prepared from whole cells using the ZR Fungal/Bacterial 
DNA MiniPrep (Zymo Research, Irvine, CA) according to vendor protocols. Strains were 
routinely cultured in Luria-Bertani (LB) broth (supplemented with antibiotics as 
necessary). Cultures were assayed for their ability to synthesize L-phenylalanine, trans-
cinnamate, and styrene by cultivation in phosphate-limited minimal media (herein 
referred to as “MM1”) with glucose. MM1 was adapted from Qi et al. (2007), and is 
composed of glucose (nominally 15 g/L), MgSO4∙7H2O (0.5 g/L), (NH4)2SO4 (4.0 g/L), 
MOPS (24.7 g/L), KH2PO4 (0.3 g/L), K2HPO4 (0.7 g/L), and 5 mL/L ATCC Trace 
Mineral Supplement (Catalog No. MD-TMS) (EDTA (0.5 g/L), MgSO4∙7H2O (3 g/L), 
MnSO4∙7H2O (0.5 g/L), NaCl (1 g/L), FeSO4∙7H2O (0.1 g/L), Co(NO3)2∙6H2O (0.1 g/L), 
CaCl2 (0.1 g/L), ZnSO4∙7H2O (0.1 g/L), CuSO4∙5H2O (0.01 g/L), AlK(SO4)2 (0.01 g/L), 
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H3BO3 (0.01 g/L), Na2MoO4∙2H2O (0.01 g/L), Na2SeO3 (0.001 g/L), Na2WO4∙2H2O 
(0.10 g/L), and NiCl2∙6H2O (0.02 g/L)). 
Table 2.1. Strains, plasmids, and oligonucleotide primers. 
 
 Description Source 
Strains 
  
E. coli NST74 
aroH367, tyrR366, tna-2, lacY5, aroF394(fbr), malT384, pheA101(fbr),pheO352, 
aroG397(fbr) 
ATCC 
31884 
E. coli BL21Star(DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Invitrogen 
E. coli NEB-10 beta 
araD139 ∆(ara,leu)7697 fhuA lacX74 galK16 galE15 mcrA f80d(lacZ∆M15)recA1 
relA1 endA1 nupG rpsL rph spoT1∆(mrr-hsdRMS-mcrBC) NEB 
S. cerevisiae W303 Source of pad1 and fdc1 MIT 
L. plantarum  Source of pdc MIT 
B. subtilis 3610 Source of padC MIT 
Plasmids 
pTrc99A Ptrc, pBR322 ori, lacI
q, Ampr MIT 
pSTV28 Plac, pACYC184 ori, Cm
r  MIT 
pSpal1At pal1 of A. thaliana inserted into the EcoRI and SphI sites of pSTV28 This study 
pSpal2At pal2 of A. thaliana inserted into the EcoRI and SphI sites of pSTV28 This study 
pSpalAv pal of A. variabilis inserted into the EcoRI and BamHI sites of pSTV28 This study 
pSpalNp pal of N. punctiforme inserted into the EcoRI and BamHI sites of  pSTV28 This study 
pSencPSm encP of S. maritimus inserted into the EcoRI and BamHI sites of  pSTV28 This study 
pTpad1Sc PAD1 of S. cerevisiae inserted into the NcoI and XbaI sites of  pTrc99A This study 
pTpad1Sc-fdc1Sc FDC1 of S. cerevisiae inserted into pTpad1Sc This study 
pTfdc1Sc FDC1 of S. cerevisiae inserted into the SalI and HindIII sites of  pTrc99A This study 
pTpadCBs padC of B. subtilis inserted into the BamHI and SbfI sites of  pTrc99A This study 
pTpdcLp pdc of L. plantarum inserted into the BamHI and SbfI sites of pTrc99A This study 
pUN15-pal1 Clone U10120 containing AT2G37040 (pal1) from A. thaliana ABRC 
pUN15-pal2 Clone U12256 containing AT3G53260 (pal2) from A. thaliana ABRC 
Primers (5' -> 3') 
  
F_pal_AV_EcoRI TAAGAATTCAAGGGGATAAATAATGAAGACACTATCTCAAGC 
 
R_pal_AV_BamHI ATTGGATCCTTAATGCAAGCAGGGT 
 
F_pal_NP_EcoRI TAAGAATTCAAGGGGATAAATAATGAATATAACATCTCTACAAC     
 
R_pal_NP_BamHI ATTGGATCCTTACGTTGACTTTAAGCT 
 
F_pal1_AT_EcoRI TAAGAATTCAAGGGGATAAATAATGGAGATTAACGGGGCAC 
 
R_pal1_AT_SphI ATTGCATGCTTAACATATTGGAATGGGAGCTC 
 
F_pal2_AT_EcoRI TAAGAATTCAAGGGGATAAATAATGGATCAAATCGAAGCAATG 
 
R_pal2_AT_SphI ATTGCATGCTTAGCAAATCGGAATCGGAG 
 
F_encP_SM_EcoRI TAAGAATTCAAGGGGATAAATAATGACCTTCGTCATAGAGCT 
 
R_encP_SM_BamHI ATTGGATCCTTAGTGCGCCGCCACG 
 
F_padC_BS_BamHI AAAGGATCCCGACTAAGGGAGGATAAGATGGAAAACTTTATCGGAAG 
 
18 
 
R_padC_BS_SbfI ATACCTGCAGGATGTTTATTATAATCTTCCCGCG 
 
F_pdc_LP_BamHI ATAGGATCCCTCTGGAGGCAGTTCTAATGACAAAAACTTTTAAAACACT 
 
R_pdc_LP_SbfI ATACCTGCAGGCCAGAATGTTTCACGTGAA 
 
F_pad1_SC_NcoI TTACCATGGAGGAACCTAGGCACACAATGGTCCTATTTCCAAGAAGAA 
 
R_pad1_SC_XbaI ATTTCTAGATTACTTGCTTTTTATTCCTTCCC 
 
F_fdc1_SC_SalI ATAGTCGACAGACATCAAAGGACGGTTCATGAGGAAGCTAAATCCAGCT 
 
R_fdc1_SC_HindIII ATTAAGCTTTTATTTATATCCGTACCTTTTCCAAT 
 
2.2.3 Toxicity assays.   
To determine extent and effects of metabolite toxicity on E. coli, the impacts of 
the exogenous addition of tCA and styrene (at increasing final concentrations) to growing 
cultures was investigated. Seed cultures of E. coli NST74 were prepared in 5 mL of LB 
broth and grown at 32
o
C overnight while shaking at 250 rpm. The seed culture (1 ml) was 
then used to inoculate 50 ml of LB broth in a 250 mL shake flask. Cultures were grown 
to an optical density (OD600) of either ~0.6 or ~2.0, at which time either tCA or styrene 
was added to the flasks at an array of final concentrations between 0 to 1 g/L. Two 
different initial OD600 levels were used to investigate the potential effects of product 
toxicity as a function of cell density and/or growth stage. In all cases, culturing then 
resumed at 32
o
C for another 6-8 h while cell growth, as determined by OD600 
measurements, was periodically monitored using a UV/Vis spectrophotometer (Beckman 
Coulter DU800, Brea, CA).  
2.2.4 Cloning of candidate genes encoding PAL activity from A. variabilis, N. 
punctiforme, and A. thaliana.   
All genes used in this study were PCR amplified using a BioRad iCycler system 
with Phusion DNA Polymerase (Finnzymes, Espoo, Finland) using custom 
oligonucleotide primers. PCR cycling and reaction conditions were standardized 
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according to manufacturer instructions. Candidate PAL encoding genes were amplified 
from the cDNA of A. variabilis and N. punctiforme. Candidate PAL encoding genes from 
A. thaliana were derived from cDNA library plasmids containing the specific loci of 
interest (Table 2.1) obtained from the ABRC (Ohio State University, Columbus, OH). 
Whereas A. thaliana posses four distinct PALs, we focused on those encoded by PAL1 
and PAL2 as these have displayed the greatest activity when expressed in recombinant E. 
coli (noting also that PAL3 was found to be of ‘very low activity’)(Cochrane, Davin, and 
Lewis 2004). Amplified linear DNA fragments were purified using the Zyppy Clean and 
Concentrator kit (Zymo Research, Orange, CA). Purified fragments were treated by 
endonuclease digestion using appropriate restriction enzymes (all from New England 
Biolabs, Ipswich, MA). Amplified fragments containing the pal from both N. punctiforme 
and A. variabilis were digested with BamHI and EcoRI whereas fragments containing 
PAL1 and PAL2 from A. thaliana were digested with EcoRI and SphI. All digestions were 
performed at 37
oC according to manufacturer’s protocols. The expression vector pSTV28 
was similarly digested with either BamHI and EcoRI or EcoRI and SphI.  Digested 
fragments were gel purified using the Zyppy Gel DNA recovery kit (Zymo Research, 
Orange, CA). Linearized fragments were ligated using T4 DNA ligase (New England 
Biolabs, Ipswich, MA) at 4
o
C overnight. Chemically competent E. coli NEB10-Beta 
(New England Biolabs, Ipswich, MA) cells were used for all transformations. 
Transformants were selected by plating on LB solid agar containing 34 mg/L 
chloramphenicol and culturing at 37
o
C overnight. The transformant pool was screened 
according to both colony PCR (employing the same primers as used in the initial 
amplification) and restriction digest mapping of the resultant plasmids to identify those 
20 
 
clones harboring the successful construct. This approach resulted in construction of 
plasmids pSpalAv, pSpalNp, pSpal1At, and pSpal2At, as listed in Table 2.1. 
2.2.5 Cloning of candidate genes encoding PADC activity from L. plantarum, B. subtilis, 
and S. cerevisiae.  
Candidate PADC encoding genes, including pdc, padC, PAD1, and FDC1, were 
amplified via PCR using genomic DNA templates derived from L. plantarum, B. subtilis, 
and S. cerevisiae, respectively. PCR amplified DNA fragments were purified before 
treatment by endonuclease digestion. Fragments containing padC and pdc were each 
digested with BamHI and SbfI.  The E. coli expression vector pTrc99A was similarly 
digested with BamHI and SbfI. Meanwhile, the amplified fragment containing PAD1 was 
digested with NcoI and XbaI whereas the FDC1 containing fragment was digested with 
SalI and HindIII. The E. coli expression vector pTrc99A was similarly digested with 
either NcoI and XbaI (for the insertion of PAD1) or SalI and HindIII (for the insertion of 
FDC1). All digested fragments were gel purified then ligated at 4
o
C overnight before 
their transformation into chemically competent E. coli NEB10-Beta.  Selection was then 
achieved by plating transformed cells on LB solid agar containing 100 mg/L ampicillin 
and culturing at 37
o
C overnight. After confirmation of the correct transformant, these 
works resulted in the generation of plasmids pTpadCBs, pTpdcLp, pTpad1Sc, and 
pTfdc1Sc, as listed in Table 2.1. The SalI-HindIII digested FDC1 fragment was then also 
cloned into the same sites in the newly generated plasmid pTpad1Sc by an analogous 
protocol, resulting in the plasmid pTpad1Sc-fdc1Sc. 
2.2.6 Assaying PAL activity in crude lysates of recombinant E. coli. 
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 Each of the newly created PAL harboring plasmids (namely pSpalAv, pSpalNp, 
pSpal1At, and pSpal2At) were individually transformed into E. coli BL21(DE3) 
(Invitrogen, Carlsbad, CA). Seed cultures of each of the resultant strains were prepared 
(in triplicate) in 5 mL LB broth supplemented with 34 mg/L chloramphenicol and 
cultured at 32°C while shaking at 250 rpm overnight. 50 µl of each seed was then used to 
again inoculate 5 ml LB broth. These cultures were grown until reaching an OD600 of 
~0.6, at which point each was induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) at a final concentration of 0.2 mM.  Induced cultures were 
incubated for an additional 6 h after which an equal number of cells (determined by 
OD600 measurement) were collected by centrifugation at 1400 x g for 4 min. The cell 
pellet was re-suspended in 900 µL distilled water. Cell lysis was achieved using the 
FastBreak Cell Lysis Reagent kit (Promega, Madison, WI) and the supernatant collected 
after centrifugation at 11,000 x g for 2 min. PAL activity was analyzed at room 
temperature in pH 7.5 50 mM Tris-HCl buffer containing 250 mM L-phenylalanine. 
Activity assays were initiated by the addition of 5 µL of crude cell lysate. The production 
of tCA was followed at 290 nm on a Beckman Coulter UV/Vis Spectrophotometer for a 
total of 5 min at 20 sec intervals. A molar extinction coefficient of 9,000 M
-1
 cm
-1
 and a 1 
cm path length were used to establish enzyme activity in terms of U mg
-1
 protein. The 
PAL protein content in each crude lysate was determined via first separation by SDS-
PAGE using Mini-PROTEAN TGX 4-20% precast gels (Bio-Rad, Hercules, CA) and 
standard protocols. Concentration was then analyzed using the ImageJ software package 
(NIH, Bethesda, MD) and calibrated versus Precision Plus Unstained Protein Standards 
(Bio-Rad, Hercules, CA).  
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2.2.7 Assaying PAL activity in recombinant E. coli whole cells.   
Seed cultures of E. coli BL21(DE3) harboring one of pSpalAv, pSpalNp, 
pSpal1At, or pSpal2At, were prepared in 5 mL LB broth and grown overnight. Shake 
flasks (250 mL) containing 50 mL of LB were inoculated with 1 mL of each seed culture. 
Cultures were grown until an OD600 of ~0.6 was reached, at which point the cultures were 
induced by IPTG addition at a final concentration of 0.2 mM. Cultures were then 
incubated for an additional 6 h (resulting in an OD600 of ~2) before an equal number of 
cells were collected and centrifuged at 1400 x g for 5 min. The pellet was washed once 
with PBS (phosphate buffered saline) at pH 7 before being re-suspended in 12 ml PBS 
buffer.  Finally, the appropriate substrate, L-phenylalanine or L-tyrosine at a final 
concentration of 1 g/L, was added to the suspension. The suspensions were then shaken at 
32°C for a total of three hours. Samples (1 mL) were taken every hour, centrifuged, and 
750 µL of supernatant was collected for HPLC analysis to monitor the production of 
either tCA or p-coumaric acid. 
2.2.8 Assaying PADC activity in recombinant E. coli whole cells.   
The plasmids pTpad1Sc-fdc1Sc, pTpad1Sc, pTfdc1Sc, pTpdcLp, and pTpadcBs 
were each individually transformed into chemically competent E. coli BL21(DE3). A 
seed culture of each strain was then grown in LB broth overnight. Shake flasks (250 mL) 
containing 50 mL of LB were inoculated with 1 ml of seed culture. Cultures were grown 
at 32°C until an OD600 of ~0.6, at which point they were induced by adding 0.2 mM 
IPTG and then incubated for an additional 6 h.  Cells were then collected and re-
suspended in 12 ml PBS buffer (as previously described) and the substrate (tCA or p-
coumaric acid) was added at a final concentration of 1 g/L. Samples (1 mL) were 
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removed from the culture at both the time of initiation as well as after 12 h of incubation 
at 32
o
C and analyzed by HPLC using the methods described herein.   
2.2.9 Co-expression of PAL and CADC isoenzymes in E. coli NST74 to convert L-
phenylalanine to styrene.   
The L-phenylalanine over-producing strain E. coli NST74 (Table 2.1) was co-
transformed with the plasmids pSpal2At and pTfdc1Sc and selected for on LB agar 
supplemented with 100 mg/L ampicillin and 34 mg/L chloramphenicol. The resultant 
transformant was then grown overnight at 32°C in 5 mL LB broth. Shake flasks (250 mL) 
containing 50 mL LB were inoculated with 1 mL of seed culture. The culture was then 
grown at 32°C until an OD600 of ~0.6, at which time it was induced with 0.2 mM IPTG 
and then incubated for an additional 8 h. Cells were then collected and re-suspended in 12 
ml PBS buffer (as previously described) and L-phenylalanine added at a final 
concentration of either 400 or 900 mg/L. Samples were taken periodically and analyzed 
by HPLC to determine the content of L-phenylalanine, tCA, and styrene, according to the 
methods presented below. 
2.2.10 Co-expression of PAL and CADC isoenzymes in E. coli NST74 to convert glucose 
to styrene in shake flask cultures.   
The L-phenylalanine over-producing strain E. coli NST74 was co-transformed 
with each of the following combinations of plasmids: pSpalAv and pTfdc1Sc, pSpalNp 
and pTfdc1Sc, pSpal1At and pTfdc1Sc, and pSpal2At and pTfdc1Sc.Single colonies 
were then selected from the resulting transformants and grown in 5 mL LB broth for 12 h 
at 32°C while shaking at 250 rpm to prepare a seed culture. Each seed (1 mL) was then 
used to inoculate 50 mL MM1. These cultures were performed in 100 mL serum bottles 
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outfitted with septa caps that were tightly sealed upon inoculation. A closed system was 
used to avoid volatile product (i.e., styrene) losses.  A large headspace was used to 
preclude the depletion of oxygen from the bottle. Cultures were grown for 10 h prior to 
being induced by the addition of IPTG at a final concentration of 0.2 mM. Culturing 
continued for 29 to 48 h post induction while 1 ml samples were periodically taken from 
each culture and analyzed for relevant metabolite contents via HPLC, using the methods 
described herein.     
2.2.11 Metabolite analysis by HPLC.   
Samples were prepared by removing 1 mL of culture from a shake flask culture 
and pelleting the cells at 11,000 x g for 2 min. The supernatant (0.75 mL) was then 
transferred to a glass HPLC vial and sealed with a Teflon-lined cap. HPLC analysis was 
carried out using a Hewlett Packard 1100 series HPLC system equipped with an auto 
sampler, diode array (UV/Vis) detector, and reverse-phase Hypersil Gold SBC18 column 
(4.6mm x 150 mm; Thermo Fisher, USA). Samples (5 µL) were injected for analysis at a 
total constant flow rate of 1.0 ml/min and constant column temperature of 45
o
C. The 
column was eluted with ‘solvent A’ (consisting of double-distilled water) and ‘solvent B’ 
(consisting of methanol (99.8% grade) plus 0.1% trifluoroacetic acid (TFA)). The eluent 
began as a mixture of 95% solvent A and 5% solvent B before a linear gradient was 
applied over 8 min to then reach a mixture of 20% solvent A and 80% solvent B. This 
eluent composition was then held constant for 2 min before a second linear gradient was 
then applied over the course of 4 min to achieve a final mixture of 95% solvent A and 5% 
solvent B. The eluent was monitored at each of 215 nm for L-phenylalanine and 258 nm 
for tCA, p-coumaric acid, hydroxystyrene and styrene. Under these conditions L-
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phenylalanine, p-coumaric acid, tCA, p-hydroxystyrene, and styrene were eluted at 4.5, 
6.7, 8.67, 8.78, and 10.4 min, respectively. 
2.2.12 Confirmation of styrene biosynthesis by GC-MS.   
Culture supernatant (1 ml) was added to hexane (1 ml) and vortexed for 20 min at 
maximum speed. The biphasic mixture was centrifuged for 1 min at 11,000 x g to settle. 
750 µl of the hexane layer was removed for analysis by GC-MS. GC-MS analysis was 
performed on a Hewlett Packard 5890 Series II gas chromatograph with a flame ionizing 
detector and Supelco MDN-5 S (30 m × 0.25 mm id) fused-silica capillary column using 
helium as the carrier gas. The injector, column, and detector temperatures were initial set 
at 280, 240, and 220 °C, respectively. The column temperature was then increased from 
40 to 320 °C at 14 °C/min.  
2.3 Results and discussion 
2.3.1 Assaying styrene toxicity.  
Under the studied conditions, maximal titers of L-phenylalanine produced by E. 
coli NST74 after 48 h of culture in MM1 (with 1.5% glucose) reached about 700-1000 
mg/L (results not shown). Whereas the theoretical yield of L-phenylalanine on glucose is 
0.55 g/g(Baez-Viveros et al. 2004), achievable yields by E. coli NST74 under the present 
conditions in shake flask cultures were only 0.052-0.074 g/g (or about 10% of 
theoretical). Assuming complete conversion of all endogenously produced L-
phenylalanine to styrene were possible (if our engineered pathway could achieve a 
particularly high flux), we would expect to be able to synthesize up to 440-630 mg/L of 
styrene under the same culture conditions (corresponding to a glucose yield of 0.051-
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0.072 g/g), barring any physiological limitations such as product toxicity. Through a 
preliminary screening study, however, we have found that the products trans-cinnamate 
(logKow = 2.13) and styrene (logKow = 3.05) can each inhibit E. coli  growth when added 
to cultures at final concentrations above ~800 mg/L and ~300 mg/L, respectively, as 
demonstrated in Fig. 2.2.  
 
Figure 2.2 Toxicity of styrene and trans-cinnamate. Left: Growth response of E. coli 
NST74 to tCA at concentrations of 0 mg/L (solid square), 200 mg/L (solid circle), 400 
mg/L (solid triangle), 600 mg/L (open square), 800 mg/L (open circle), and 1000 mg/L 
(open triangle). Right: Growth response of E. coli NST74 to styrene at concentrations of 
0 mg/L (solid square), 100 mg/L (solid circle), 200 mg/L (solid triangle), 300 mg/L (open 
square), 400 mg/L (open circle), and 500 mg/L (open triangle). Error bars reported at one 
standard deviation from triplicate experiments. 
 
For reference, p-hydroxystyrene (logKow = 2.28) has previously been shown to 
inhibit P. putida at concentrations of ~540 mg/L(Verhoef et al. 2009). Solvent 
hydrophobicity is typically a good indicator of its toxicity towards microorganisms and 
may be quantified by logKow, the log of the octanol-water partition coefficient(Ramos, 
Duque, Gallegos, Godoy, Ramos-González, et al. 2002). Even at low concentrations, 
compounds with a logKow between 1.0 to 5.0 tend to be very toxic(Heipieper, Weber, 
Sikkema, Keweloh, and de Bont 1994). Accumulation of hydrophobic aromatics within 
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the cytoplasmic membrane has been shown to disrupt its integrity, resulting in the 
leakage of ions, metabolites, lipids, and proteins, as well as affecting the cells ability to 
maintain its internal pH and an appropriate transmembrane proton gradient(Ramos, 
Duque, Gallegos, Godoy, Ramos-González, et al. 2002; Weber et al. 1993). The 
measured toxicity thresholds were found to be consistent at both low (OD600 0.6) and 
high (OD600 2, data not shown) initial cell densities (reflecting early and late exponential 
growth, respectively), indicating growth inhibition was independent of cell density and 
growth stage. As a result of the inherent toxicity of styrene we anticipated that its 
biosynthesis using an NST74 host platform would be limited to below its maximum 
potential under our culture conditions. While no prior studies have specifically explored 
either the effects of styrene toxicity on E. coli or strategies to improve its tolerance,  
several Pseudomonas sp. have been shown to display enhanced styrene tolerance 
characteristics(Weber et al. 1993). Whereas the present study is solely focused on the 
prototyping of a novel pathway for styrene biosynthesis, it is clear from our preliminary 
assays that styrene toxicity must eventually be overcome or effectively circumvented if 
renewable styrene production is ever to become viable or sustainable.  
2.3.2 Screening candidate PAL isoenzymes for activity in recombinant E. coli.  
The activities of recombinant PALs from various genetic sources were analyzed 
according to both in vitro (crude lysate) and in vivo (whole, resting cell) assays. All 
recombinant PALs, expressed from plasmids pSencPSm, pSpalAv, pSpalNp, pSpal1At, 
and pSpal2At (Table 2.1) in an E. coli BL21(DE3) background were recovered as crude 
lysates. According to our in vitro assay results, all of the tested PALs showed comparable 
levels of activity on L-phenylalanine as substrate (Table 2.2), with the exception of EncP 
28 
 
from S. maritimus whose activity was non-measureable. It has previously been shown 
through kinetic studies on  prokaryotic PALs that those derived from N. puntiformes and 
A. variabilis possessed 500-1000 times greater activity than EncP from S. maritimus; 
furthermore, the kcat/Km value of PAL from A. variabilis was found to be greater than that 
of N. puntiformes (72.2 and 43.8 mM
-1
s
-1
, respectively)(Moffitt et al. 2007). Thus, it is 
possible that EncP was in fact functionally expressed in our study; however, its activity 
was too low to measure according to the protocols employed. The relative activities of 
candidate PALs were then further explored through the use of whole-cell assays in 
recombinant E. coli. Resting cells suspended in PBS buffer (pH 7) were supplemented 
with L-phenylalanine or L-tyrosine and product (tCA or p-coumaric acid, respectively) 
formation was monitored over the course of 3 h. Although the PALs from A. thaliana 
were found to possess the greatest specific activity in crude lysates (Table 2.2), assays of 
in vivo function provided a more stark contrast into the relative activities among all 
candidate PALs, as shown in Fig. 2.3. 
Table 2.2 PAL Specific Activity. Specific activity of PAL isoenzymes from A. 
variabilis, N. punctiforme, and A. thaliana on L-phenylalanine and L-tyrosine when 
expressed in recombinant E. coli BL21(DE3).  
Strain Substrate Activity (U mg
-1
 protein) 
BL21(DE3) L-phenylalanine n.d. 
 L-tyrosine n.d. 
pSencPSm L-phenylalanine n.d. 
 L-tyrosine n.d. 
pSpalAv L-phenylalanine 2.38 ± 0.64 
 L-tyrosine n.d. 
pSpalNp L-phenylalanine 0.91 ± 0.32 
 L-tyrosine n.d. 
pSpal1At L-phenylalanine 2.42 ± 1.07 
 L-tyrosine n.d. 
pSpal2At L-phenylalanine 4.08 ± 0.11 
 L-tyrosine n.d. 
n.d. – not detected 
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Figure 2.3 PAL Activity. Phenylalanine ammonia lyase activity from candidate genes 
cloned from A. thaliana, A. variabilis, and N. punctiformes in recombinant E. coli 
BL21(DE3) whole cells. 50 ml cultures were grown for 8 h (induced with 0.2 mM IPTG 
after 1.5 h), spun down and resuspended in 10 ml PBS buffer. The conversion of 1 g/L L-
phenylalanine (black) to trans-cinnamic acid after 1 h (no color), 2 h (light gray), and 3h 
(dark gray). Error bars reported at one standard deviation from triplicate experiments.  
 
Under the studied conditions, the PALs of A. thaliana were found to display the 
greatest activity (being significantly higher that of either prokaryotic PAL) although 
being comparable for both isoenzymes. This result is more consistent with previous 
studies wherein kcat/Km values of PAL1 and PAL2 were estimated as 25,500 and 51,200 
M
-1
s
-1
 (or six orders of magnitude greater than those reported for N. puntiformes and A. 
variabilis) when expressed in recombinant E. coli (Cochrane, Davin, and Lewis 2004). 
The elevated relative activity of PAL2 is also consistent with the observation of higher 
initial rates of tCA accumulation when expressed from BL21(DE3) pSpal2At, as seen in 
Fig. 2.3. Again, however, none of the tested PAL isoenzymes were found to display any 
activity on L-tyrosine as the substrate (data not shown), which is consistent with the 
results of our in vitro assays (Table 2.2). Taken together, these analyses demonstrate that 
all of the studied PALs display rigid substrate specificity for L-phenylalanine. This 
important result contrasts numerous prior works on aromatic pathway development in 
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recombinant E. coli which have solely relied upon the use of bifunctional yeast 
PAL/TALs(Gilbert et al. 1985; Gilbert and Tully 1982; Gilbert, Stephenson, and Tully 
1983; Cui, Jia, and Sun 2008) and, which was specifically used to synthesize p-
hydroxystyrene(Qi et al. 2007). As these results illustrate that the first committed step in 
our pathway is highly specific for the intended substrate (L-phenylalanine) alone, we 
anticipate that this advantageous outcome will ultimately help to control product purity 
(specifically styrene over p-hydroxystyrene or a mixture of products) while also 
improving the activity and flux of our desired pathway. Meanwhile, the same cannot be 
assured had the first committed step of our pathway been catalyzed by PAL/TAL, as was 
the case for all engineered p-hydroxystyrene pathways reported to date(Qi et al. 2007; 
Verhoef et al. 2009).  
 2.3.3 Screening candidate PADC isoenzymes for tCA decarboxylase activity in 
recombinant E. coli.  
Candidate PADC isoenzymes from L. plantarum, B. subtilis, and S. cerevisiae 
were screened for their ability to decarboxylate tCA to produce styrene when expressed 
in E. coli.  Plasmids harboring the candidate PADC-encoding genes (Table 2.1) were 
individually transformed into E. coli BL21(DE3), as described above. Whole, resting 
cells were prepared in PBS buffer supplemented with 1g/L of tCA acid or p-coumaric 
acid. The production of styrene or p-hydroxystyrene, respectively, was then followed 
periodically, and the results after 12 h of culture are compared in Fig. 2.4. With the 
exception of the strain expressing PAD1 from S. cerevisiae alone, all other strains 
displayed decarboxylase activity on p-coumaric acid, leading to p-hydroxystyrene 
biosynthesis. These results are consistent with previous reports on the functional 
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expression of pdc and padC in recombinant E. coli(Qi et al. 2007) to support p-
hydroxystyrene biosynthesis from glucose. However, our findings further and 
importantly show that the enzymes from L. plantarum and B. subtilis cannot catalyze the 
conversion of tCA to styrene (thus making them more specific for p-coumaric acid). In 
the present study it was instead found that the sole expression of FDC1 from S. cerevisiae 
(which was previously characterized to encode a ferulic acid decarboxylase) was 
sufficient for achieving decarboxylase activity on either tCA or p-coumaric acid (with 
perhaps a slight preference towards tCA, based on overall conversion). Though it was 
previously reported that the co-expression of both FDC1 and PAD1 is necessary to 
achieve tCA decarboxylase activity in the native S. cerevisiae (Mukai et al. 2010), we 
now report that functional tCA decarboxylase activity in E. coli depends solely upon 
FDC1 over-expression and is not dependent upon the co-expression of PAD1. 
Furthermore, as can be seen in Fig. 2.4, comparable styrene titers were achieved when 
either FDC1 was expressed alone or together with PAD1, indicating that the co-
expression of PAD1 does not increase (or otherwise alter) tCA decarboxylase activity in 
E. coli, as has previously been suggested in the native S. cerevisiae (Larsson et al., 2001). 
It is, however, plausible that the expression of ubix (which has been shown to be 50% 
similar to PAD1(Mukai et al. 2010)) in our E. coli background could have served to 
compensate for the absence of PAD1 expression, enabling tCA decarboxylase activity to 
be achieved in E. coli expressing FDC1 alone. Future studies will explore the deletion of 
ubix from the background of E. coli to further investigate the recombinant function of 
FDC1. Most importantly, these results have demonstrated that FDC1 over-expression in 
E. coli uniquely enables the decarboxylation of tCA to styrene. 
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Figure 2.4 PADC Activity. Phenylacrylic acid decarboxylase activity from candidate 
genes cloned from S. cerevisiae, L. plantarum, and B. subtilis in recombinant E. coli 
BL21(DE3) whole cells. The conversion of A) 1 g/L p-coumaric acid (dark gray) to p-
hydroxystyrene (light gray) and B) 1 g/L trans-cinnamic acid (dark gray) to styrene (light 
gray) after 12 h. Error bars reported at one standard deviation from triplicate experiments. 
 
Although the proposed styrene biosynthesis pathway is somewhat analogous to 
that which was previously developed for p-hydroxystyrene biosynthesis(Qi et al. 2007; 
Verhoef et al. 2009), it is essential to realize that the specific enzyme ‘parts’ used in those 
two prior studies are wholly inadequate for achieving the present objective of styrene 
biosynthesis from glucose. In other words, said previously-characterized enzymes were 
not simply transferrable among the two (styrene and p-hydroxystyrene) distinct 
pathways, but rather that styrene biosynthesis could only be supported through the 
identification and characterization of a specific tCA decarboxylase. 
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2.3.4 Biosynthesis of tCA and styrene from glucose in recombinant E. coli.   
The biosynthesis of tCA from glucose was first investigated using strains of E. 
coli NST74 that individually carried the plasmids pSpalAv, pSpalNp, pSpal1At, and 
pSpal2At. Cultures were grown in MM1 media with 1.5% glucose. 48 h after induction 
with 0.2 mM IPTG, the production of tCA was detected in each culture at final titers of 
600 mg/L, 473 mg/L, 648 mg/L, and 918 mg/L, respectively. Neither styrene nor p-
coumaric acid were detected in any samples.   
To test for styrene biosynthesis from glucose, FDC1 from S. cerevisiae was then 
co-expressed with each of the PAL-encoding genes according to the following 
constructed strains: NST74 pSpalAv pTfdc1Sc, NST74 pSpalNp pTfdc1Sc, NST74 
pSpal1At pTfdc1Sc, and NST74 pSpal2At pTfdc1Sc. Conversion of glucose to styrene 
was followed after IPTG induction and results for the strain NST74 pSpal2At pTfdc1Sc 
are shown in Table 2.3 (other results not shown as this dataset was representative of the 
results and trends observed with all other strains). Substantial L-phenylalanine 
accumulation was not observed until 17 h post induction, after which time styrene titers 
then also rose considerably, reaching a final titer of 260 mg/L in the culture medium 29 h 
post-induction. The final styrene titers for the strains NST74 pSpalAv pTfdc1Sc, NST74 
pSpalNp pTfdc1Sc, and NST74 pSpal1At pTfdc1Sc were found to be 210, 183, and 188 
mg/L, respectively.  
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Table 2.3 Styrene Fermentation Titers. Biosynthesis of L-
phenylalanine, trans-cinnamic acid, and styrene by E. coli 
NST74 pSpal2At pTfdc1Sc from glucose in MM1 media. 
Errors reported at one standard deviation from triplicate 
experiments. 
time (h) 
L-phenylalanine 
(mg/L) 
trans-cinnamic 
acid (mg/L) 
styrene 
(mg/L) 
0 13.9 ± 0.03 0 0 
13 56.4 ± 0.13 3.7 ± 0.01 7.3 ± 0.12 
17 236.5 ± 0.57 6.3 ± 0.01 23 ± 0.38 
21 167.4 ± 0.40 9.1 ± 0.02 205 ± 3.40 
25 152.2 ± 0.36 13.5 ± 0.02 243 ± 4.03 
29 179.5 ± 0.43 14.0 ± 0.03 260 ± 4.31 
 
As styrene-producing strains were cultured, a strong ‘hydrocarbon’ aroma was 
readily detected upon opening the sealed culture bottles. The high volatility of styrene 
necessitated the use of sealed jars for culturing. To ensure that sufficient oxygen 
remained available to the culture, a large headspace volume (200 mL headspace vs. 50 
mL media) was used. Thus, cultures were maintained under aerobic conditions 
throughout the culture (as confirmed by the inclusion of the indicator dye resazurin). 
However, the use of such a large headspace volume also allows for the significant 
accumulation of styrene vapor, which should also be accounted for when assessing 
productivity. Under dilute and near-ambient conditions, the equilibrated headspace vapor 
composition can be estimated by application of Henry’s Law. Using a dimensionless 
Henry’s Law constant of 0.113(Yang 1992), it can be predicted that a headspace 
equilibrated with an aqueous phase containing 260 mg/L styrene will contain an 
additional 29 mg/L styrene, for a total of 18.9 mg in the 250 mL flask (note this would be 
equivalent to an aqueous titer of 376 mg/L if no volatilization had occurred). In an 
analogous manner, the final styrene production by strains NST74 pSpalAv pTfdc1Sc, 
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NST74 pSpalNp pTfdc1Sc, and NST74 pSpal1At pTfdc1Sc would be estimated as 15.2, 
13.4, and 13.6 mg, respectively. 
Following these fermentation studies, culture supernatants were extracted using 
hexane, and the extracts were analyzed by GC-MS to confirm that it was in fact styrene 
that was being synthesized by our cultures. Comparing the spectra of the dominant 
metabolite peak which was recovered from the extract to the NIST08 spectral 
database(Babushok et al. 2007),  styrene was found to be the most probable compound. 
As can be seen from Fig. 2.5, the mass spectra of the extracted sample and the library 
reference provide an excellent match, providing confirmation that styrene was in fact 
synthesized by our engineered strains of E. coli.  
 
 
Figure 2.5 Mass spectra of styrene. Head to tail comparison of the standard mass 
spectra showing the relative abundance of the mass-to-charge ratio of styrene from the 
NIST08 library (lower) with that of the dominant metabolite peak obtained in hexane 
extractions of the culture broth (upper). 
 
Throughout the duration of culture, never was all of the L-phenylalanine observed 
to be fully assimilated into the styrene pathway (as seen in Table 2.3). Furthermore, tCA 
titers were observed to remain low throughout, indicating that almost all of the 
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synthesized tCA could be quickly converted to styrene. Taken together, these 
observations suggest that low PAL activity presently remains as the flux limiting 
condition in the engineered styrene biosynthesis pathway.  As the first committed step in 
the styrene pathway, high PAL activity is essential and must be improved in subsequent 
generations of our strains. To start, the expression of PAL can likely be improved through 
the use of codon optimized variants. This approach has shown to be useful, particularly in 
cases for which pathways involve the expression of plant-derived genes in E. coli.  For 
example, codon optimization was applied to the amorphadiene oxidase from Artemisia 
annua (a plant species) as part as a synthetic pathway to produce artemisinic 
acid(Keasling 2008). Whereas the native protein originally showed neither in vivo nor in 
vitro activity when expressed in E. coli, a codon optimized variant resulted in its 
functional expression in E. coli, contributing to successful pathway development. 
Whereas improvements in PAL expression can lead to enhancements in the 
specific metabolite flux, the net flux can also be improved by increasing the pathway 
‘driving force’.  That is, by promoting the increased availability of the pathway’s 
immediate precursor, L-phenylalanine.  This notion was tested in resting cells assays 
wherein E. coli NST74 pSpal2At pTfdc1Sc cell suspensions were supplemented with 
exogenous L-phenylalanine at initial concentrations of either 400 or 950 mg/L. As shown 
in Fig. 2.6, the conversion of 400 mg/L L-phenylalanine to styrene occurred rapidly and 
completely (i.e., no residual L-phenylalanine or tCA was detectable), yielding a final 
styrene titer of 250 mg/L after 30 h.  Meanwhile, when 950 mg/L L-phenylalanine was 
added to the resting cell cultures, nearly 500 mg/L styrene could be produced as all of the 
L-phenylalanine was consumed. However, in this case, nearly an additional 250 mg/L 
37 
 
tCA also remained in the culture. Noting that such a final styrene titer actually surpasses 
the toxicity threshold of growing cells, it is not altogether surprising that the reaction was 
unable to proceed to completion. The final styrene titer was only able to surpass the 
toxicity threshold of 300 mg/L because the cells grew to stationary phase and have 
already assembled the necessary enzymes. In this case, 500 mg/L represents an enzymatic 
inhibition imposed by styrene rather than a cellular growth inhibition as previously 
described. 
 
Figure 2.6. Whole cell styrene production. Whole cell production of styrene (triangle) 
from trans-cinnamic acid (circle) after exogenous L-phenylalanine (square) addition by 
E. coli NST74 pSpal2At pTfdc1Sc.  Open and filled shapes correspond to the initial 
addition of 400 and 950 mg/L L-phenylalanine.   
 
These results demonstrate that if the L-phenylalanine precursor pool can be 
enhanced the net production of styrene can also be increased. Clearly, however, the 
addition of exogenous L-phenylalanine is not a sustainable approach towards enhancing 
styrene biosynthesis, but rather endogenous L-phenylalanine production must be 
enhanced in our host platform. Subsequent studies will explore the incorporation of 
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additional modifications into the genome of the E. coli NST74 host that have previously 
been shown by other groups to result in L-phenylalanine yield enhancements. For 
instance, it has been reported that the over-expression of endogenous transketolase I 
(encoded by tktA) supports elevated L-phenylalanine biosynthesis(Gosset, Yong-Xiao, 
and Berry 1996). TktA over-expression enables the enhanced biosynthesis of erythrose 4-
phosphate (E4P) which, when condensed with phosphoenolpyruvate (PEP), yields 3-
deoxy-D-arabino-heptulosonate 7-phosphate (DAHP), the first committed intermediate in 
the aromatic amino acid biosynthesis pathway(Flores et al. 1996; Lütke-Eversloh and 
Stephanopoulos 2008). Meanwhile, disruption of the global carbon storage regulatory 
system of E. coli through deletion of csrA, increases PEP biosynthesis, leading to up to a 
2-fold enhancement in L-phenylalanine yield(Tatarko and Romeo 2001).   
For microbially-derived, renewable styrene to become an economically-viable 
and sustainable alternative to petroleum-derived predecessor, titers and productivity must 
ultimately be improved. Although the styrene titers achieved by our 1
st
 generation strains 
were modest, in comparison to the toxicity assays performed above it can be seen that 
they are already approaching the inhibitory threshold. Thus, whereas increasing L-
phenylalanine yields could eventually translate into elevated styrene production, product 
toxicity would soon become the subsequent limiting factor and must be addressed. As 
complex phenotypes such as solvent tolerance are simply not monogenic in nature(Alper 
et al. 2006), numerous specific mutations must applied in concert to achieve the 
specifically desired result. Since little is presently known of styrene toxicity or tolerance, 
rational approaches to engineering more tolerant strains may be less suitable than higher 
throughput, combinatorial strategies. Although commonly employed, combinatorial 
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approaches towards enhancing desired phenotypes often rely upon the aggressive use of 
chemomutagenesis, such techniques are less desirable as they can also result an 
unforeseen and difficult to understand negative impacts on host fitness and/or 
productivity(Bonomo et al. 2006), in addition to requiring laborious screening and 
selection procedures. A more effective approach for the present application might involve 
the use of an alternative host platform which inherently boasts greater tolerance(Fischer, 
Klein-Marcuschamer, and Stephanopoulos 2008), a strategy which has been applied for 
the production of biofuels, such as n-butanol(Nielsen et al. 2009). The bacterium P. 
putida S12 has been engineered, for example, as a solvent tolerant platform for the 
biosynthesis of both p-hydroxybenzoate and p-hydroxystyrene(Verhoef et al. 2007; 
Verhoef et al. 2009), and might also make excellent starting point for styrene production. 
Since our pathway is derived from the ubiquitous, proteinogenic amino acid L-
phenylalanine, its transference to an alternative host platform remains wholly compatible. 
Alternatively, improved product tolerance can also be achieved through genome 
evolution, as accomplished through serial adaptations to increasing styrene 
concentrations. Such an approach has worked well for achieving tolerance to biofuels like 
n-butanol and could also be coupled with genomic library screens to provide the first 
comprehensive view of styrene inhibition and tolerance in E. coli(Reyes, Almario, and 
Kao 2011). In an interesting example, prior works have shown that Pseudomonas sp. may 
be adapted to styrene when also grown in the presence of acetate or similar carboxylic 
acids as the sole carbon source(Weber et al. 1993). It has been suggested that this evolved 
phenotype may be associated with genetic changes leading to reductions in membrane 
fluidity, as well as through the activation of genes believed to be specifically associated 
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with enhanced tolerance to aromatic compounds. As an alternative strategy, 
combinatorial procedures such as the global Transcription Machinery Engineering 
(gTME)(Alper et al. 2006; Nicolaou, Gaida, and Papoutsakis 2010) may be implemented 
to improve styrene tolerance in E. coli or alternative host platforms selected due to their 
elevated tolerance baseline. The principals of gTME have been successfully employed to 
enhance ethanol tolerance in both yeast(Alper et al. 2006) and E. coli(Alper and 
Stephanopoulos 2007).  
 In addition to the development of styrene tolerant phenotypes, product toxicity 
can also be enhanced through the use of in situ product recovery (ISPR).  Common ISPR 
approaches involve solvent extraction(Gyamerah and Glover 1996; Malinowski 2001; 
Weilnhammer and Blass 1994), adsorption(Nielsen, Amarasiriwardena, and Prather 
2010; Nielsen and Prather 2009), gas and vacuum stripping(Loser et al. 2005), and 
membrane pervaporation(Vane 2005).  Each of these approaches has been successfully 
applied for the continuous recovery of biofuel compounds such as ethanol, for example, 
and even aromatics like L-phenylacetylcarbinol(Khan and Daugulis 2010) and 
benzaldehyde(Jain, Khan, and Daugulis 2010).  The latter three approaches may be 
particularly well-suited for styrene recovery given its volatile nature, as previously 
discussed.  
2.4 Conclusion 
For the first time, the present study has demonstrated the biosynthesis of styrene 
from renewable resources using an engineered microbial platform.  Whereas low activity 
of pathway enzymes and product toxicity remain as challenges which limit the 
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productivity of our styrene-producing strains, continued improvements will lead to the 
development of robust biocatalysts for the sustainable production of this important, large 
volume, commodity chemical.   
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CHAPTER 3 
BIOSYNTHESIS OF (S)-STYRENE OXIDE AND  (R)-1,2-PHENYLETHANEDIOL 
FROM GLUCOSE 
Abstract 
(S)-Styrene oxide and (R)-1,2-phenylethanediol are chiral aromatic molecular 
building blocks used commonly as precursors to pharmaceuticals and other specialty 
chemicals. Two pathways have been engineered in E. coli for their individual 
biosynthesis directly from glucose. The novel pathways each constitute extensions of the 
previously engineered styrene pathway, developed by co-expressing either styrene 
monooxygenase (SMO) or styrene dioxygenase (SDO) to convert styrene to (S)-styrene 
oxide and (R)-1,2-phenylethanediol, respectively.  StyAB from Pseudomonas putida S12 
was determined to be the most effective SMO. SDO activity was achieved using 
NahAaAbAcAd of Pseudomonas sp. NCIB 9816-4, a naphthalene dioxygenase with 
known broad substrate specificity. Production of phenylalanine was enhanced through a 
number of mutations, most notably via deletion of tyrA and over-expression of tktA. As a 
result, (R)-1,2-phenylethanediol reached titers as high as 1.23 g/L, and at 1.32 g/L (S)-
styrene oxide titers already approach their toxicity limit. This study additionally 
demonstrates that greater flux through the styrene pathway can be achieved if its toxicity 
is addressed, as achieved in this case by reacting styrene to less toxic products. 
This work was published as: McKenna, R., Pugh, S., Thompson, B. & Nielsen, D.R. 
Microbial production of the aromatic building-blocks (S)-styrene oxide and (R)-1,2-
phenylethanediol from renewable resources. Biotechnology Journal 8, 1465-1475 (2013). 
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3.1 Introduction 
 (S)-Styrene oxide and (R)-1,2-phenylethanediol (also referred to as (R)-styrene 
glycol) are chiral aromatic molecules used in the synthesis of numerous high value 
pharmaceuticals and specialty chemicals. For example, (S)-styrene oxide is used as a 
precursor to the biocides levamisole and nematocide (Park, So, et al. 2006), as well as in 
the synthesis of cosmetics (Loprieno et al. 1976), surface coatings, and numerous 
agricultural and biological chemicals (Panke et al. 2000; Han et al. 2006). Meanwhile, 
(R)-1,2-phenylethanediol is an optically active diol and precursor to the pharmaceuticals 
(R)-norfluoxetine and (R)-fluoxetine (used to treat psychiatric and metabolic disorders), 
as well as β-lactam antibiotics (Cao et al. 2006; Kumar, Upadhyay, and Pandey 2004). 
Additionally, (R)-1,2-phenylethanediol is also used in the production of various 
agrochemicals and pheromones (Gamenara and Dominguez de Maria 2009), as well as 
chiral catalysts (King et al. 1979).  Conventional production of (S)-styrene oxide occurs 
by the partial oxidation of styrene, most often over a heavy metal catalyst. This 
chemocatalytic process offers little control over product stereochemistry, and yields (S)-
styrene oxide at only 48 to 57% enantiomeric excess (Groves and Myers 1983; Zhang et 
al. 1990) resulting in a mixture of isomers that must then be further processed to resolve 
and isolate the desired (S)-enantiomer. As (R)-1,2-phenylethanediol is conventionally 
produced from (S)-styrene oxide via a hydrolytic ring opening reaction, its enantiopurity 
ultimately depends upon that of the substrate.  
In contrast to heavy metal and other chemocatalysts, more stereoselective enzyme 
biocatalysts can often provide greater control over product enantiopurity, while offering 
additional benefits such as a reduced environmental footprint. For example, the 
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enzymatic conversion of styrene to (S)-styrene oxide via styrene monooxygenase (SMO) 
has been extensively studied, with high conversion and enantiopurity (>99% e.e.) 
routinely reported (Panke et al. 1998; Archelas and Furstoss 1997; Panke et al. 2000). 
Two distinct biosynthetic routes to (R)-1,2-phenylethanediol, meanwhile, have been 
previously described in the literature, each involving a single-step enzyme 
biotransformation.  For example, it has been shown that (S)-styrene oxide can be 
transformed to (R)-1,2-phenylethanediol via the expression of an epoxide hydroxylase 
(EH).  Well-characterized EH homologs include those from bacteria such as Caulobacter 
crescentus (Min and Lee 2012) and  Agrobacterium radiobacter AD1 (Rui et al. 2005), 
as well as potato (Solanum tuberosum) (Monterde et al. 2004). Alternatively, it has also 
been shown that styrene itself can instead be directly dihydroxylated to (R)-1,2-
phenylethanediol at high conversion/yields and up to 74% e.e. via the expression of a 
Pseudomonas sp. naphthalene dioxygenase that also displays broad substrate specificity 
(Lee and Gibson 1996).  
However, just as with conventional industrial production of (S)-styrene oxide and 
(R)-1,2-phenylethanediol, such single-step enzymatic biotransformations are similarly 
limited by the need to supply substrates (i.e., styrene or (S)-styrene oxide) derived from 
non-renewable, petroleum feedstocks. Accordingly, previous enzymatic 
biotransformation studies have yet to address concerns over renewability and 
sustainability. In view of declining petroleum reserves and their ever-increasing costs, the 
ability to produce chiral aromatic building blocks such as (S)-styrene oxide and (R)-1,2-
phenylethanediol directly from renewable resources using microbial biocatalysts would 
represent a more sustainable approach. The engineering of a styrene biosynthesis 
45 
 
pathway in Escherichia coli (McKenna and Nielsen 2011) has recently, and for the first 
time, enabled such a prospect. Building upon the styrene bioproduction platform, the 
focus of this study was to systematically engineer novel enzyme pathways and microbial 
biocatalysts to enable both (S)-styrene oxide and (R)-1,2-phenylethanediol to be 
synthesized as individual products from renewable sugars alone.   
 As shown in Fig. 3.1, the proposed (S)-styrene oxide and (R)-1,2-
phenylethanediol pathways essentially represent extensions of the previously-engineered 
styrene pathway, and thus similarly utilize L-phenylalanine as their immediate 
endogenous precursor (McKenna and Nielsen 2011). As has been shown, phenylalanine 
can be deaminated to trans-cinnamate by a phenylalanine ammonia lyase (PAL); for 
example, PAL2 from Arabidopsis thaliana was previously found to display both high 
recombinant activity in E. coli and strict substrate specificity for phenylalanine 
(McKenna and Nielsen 2011). trans-Cinnamate can then be decarboxylated to styrene by 
a phenylacrylate decarboxylase (PADC), a reaction that to date has only been proven to 
be catalyzed by FDC1 (originally characterized as a ferulate decarboxylase) from 
Saccharomyces cerevisiae (McKenna and Nielsen 2011). Once synthesized 
endogenously, styrene could potentially then be oxidized to either (S)-styrene oxide or 
(R)-1,2-phenylethanediol via co-expression of a third, appropriate oxidase. (S)-Styrene 
oxide production, for instance, could be achieved by co-expressing a suitable styrene 
monooxygenase (SMO), whereas (R)-1,2-phenylethanediol could be achieved by co-
expressing a suitable styrene dioxygenase (SDO).   
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Figure 3.1. (S)-styrene oxide and (R)-1,2-phenylethanediol pathway. The proposed, 
non-natural pathways for the individual production of (S)-styrene oxide and (R)-1,2-
phenylethanediol from glucose.  Pathways are shown in relation to E. coli’s native 
glycolysis and aromatic amino acid biosynthesis pathways. Multiple arrows represent 
multiple steps not illustrated. (Gly-3P: glycerol-3-phosphate, Fru-6P: fructose-6-
phosphate, Xyl-5P: xylose-5-phosphate, PEP: phosphoenolpyruvate, E-4P: erythrose-4-
phosphate, DAHP: 3-deoxy-D-arabino-heptulosonate-7-phophate, DHQ: 3-
dehydroquinate). 
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Enzymatic oxidation is typically the first step associated with the aerobic 
biodegradation of styrene (as well as other aromatics), a process that numerous 
Pseudomonas sp. have been naturally evolved to perform and for which they particularly 
are well renowned (Smith 1990; Stanier, Palleroni, and Doudoroff 1966).   Accordingly, 
pseudomonads represent a useful genetic repository for SMO and SDO encoding genes. 
To date, several isoenzymes displaying SMO activity have been identified and 
characterized in Pseudomonas sp., including, for example, StyAB from P. putida S12, 
XylMA (originally characterized as xylene monooxygenase) from P. putida mt-2, and 
CymA1A2 (originally characterized as cymene monooxygenase) from P. putida F1 
(Nishio et al. 2001; Wubbolts, Reuvekamp, and Witholt 1994; Panke et al. 1998). All 
three are two-component monooxygenases consisting of an FAD-dependent hydroxylase 
(StyA, XylM, CymA1, respectively) and an NADH-FAD oxidoreductase (StyB, XylA, 
CymA2, respectively) (Nishio et al. 2001; Wubbolts et al. 1994; Wubbolts, Reuvekamp, 
and Witholt 1994; Otto et al. 2004). The epoxidation of styrene to (S)-styrene oxide 
accordingly requires FADH2, which is in turn regenerated through NADH oxidation (Otto 
et al. 2004). On the other hand, whereas no specific SDOs have been reported in the 
literature to date, as a result of its very relaxed substrate specificity, naphthalene 
dioxygenase of P. putida NCIB 9816-4 (encoded by the nahAaAbAcAd operon) has been 
shown capable of utilizing styrene as an alternative substrate, oxidizing it directly to (R)-
1,2-phenylethanediol (Lee and Gibson 1996). NahAaAbAcAd is also a multi-component 
enzyme, containing an iron-sulfur flavoprotein reductase, an iron-sulfur ferredoxin, and a 
two-subunit oxygenase. Similar to SMO, oxidized cofactors are ultimately regenerated by 
the consumption of NAD(P)H. 
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3.2 Materials and Methods 
3.2.1 Strains and media   
All strains and plasmids used in this study are listed in Table 1. Custom 
oligonucleotides were synthesized by Integrated DNA Technologies (IDT, Coralville, 
IA). Genomic DNA (gDNA) templates were prepared from whole cells using the Zyppy 
Fungal/Bacterial DNA MiniPrep kit (Zymo Research, Irvine, CA) according to vendor 
protocols. Strains were routinely cultured in Luria-Bertani (LB) broth supplemented with 
appropriate antibiotics, as necessary, at the following final concentrations: 100 mg/L 
ampicillin, 34 mg/L chloramphenicol, and 50 mg/L kanamycin. As required, auxotrophic 
strains were additionally supplemented with tyrosine and tryptophan, each initially at 50 
mg/L. All cultures were grown aerobically at 32
o
C with shaking at 250 rpm, unless 
otherwise noted. Seed cultures were prepared in 5 mL of LB broth with appropriate 
antibiotics and grown overnight. A 1%v./v. seed was then used to inoculate all flask 
cultures. To test for production of aromatic species, strains were cultivated in shake 
flasks (250 mL) containing 50 mL phosphate-limited minimal media (MM1) with 
1.5%w./v. glucose, as previously described (McKenna and Nielsen 2011).  Cultures were 
grown until an OD600 of ~0.6, at which point they were induced by 0.2 mM IPTG 
addition and incubated an additional 72 h. Samples were taken at 24 h intervals and 
analyzed by HPLC to determine concentrations of phenylalanine, trans-cinnamate, 
styrene, (S)-styrene oxide, and (R)-1,2-phenylethanediol. 
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Table 3.1. Strains and plasmids used in this study. 
  Description Source 
Strains 
  
E. coli NST74 
aroH367, tyrR366, tna-2, lacY5, aroF394(fbr), malT384, pheA101(fbr),pheO352, 
aroG397(fbr) ATCC 31884 
E. coli BL21Star(DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Invitrogen 
E. coli NEB-10 beta 
araD139 ∆(ara,leu)7697 fhuA lacX74 galK16 galE15 mcrA f80d(lacZ∆M15)recA1 
relA1 endA1 nupG rpsL rph spoT1∆(mrr-hsdRMS-mcrBC) NEB 
S. cerevisiae W303 Source of  FDC1 Prather Lab, MIT 
P. putida S12 Source of styAB Prather Lab, MIT 
P. putida mt-2 Source of xylMA DSMZ 3931 
P. putida F1 Source of cymA1A2 ATCC 700007 
P. putida NCIB 9816-4 Source of nahAaAbAcAd DSMZ 8368 
N74SO E. coli NST74 harboring the plasmids pTpal-fdc and pTKstyAB This study 
N74PED E. coli NST74 harboring the plasmids pTpal-fdc and pTKnah This study 
NST74aroB E. coli NST74 harboring the plasmid pSaroB This study 
NST74tktA E. coli NST74 harboring the plasmids pStktA This study 
NST74aroBtktA E. coli NST74 harboring the plasmids pSaroBtktA This study 
N74dA E. coli NST74 ΔtyrA This study 
N74dAdE E. coli NST74 ΔtyrA ΔtrpE This study 
N74dAtktA E. coli NST74 ΔtyrA harboring the plasmid pStktA This study 
N74dAaroB E. coli NST74 ΔtyrA harboring the plasmid pSaroB This study 
N74dAaroBtktA E. coli NST74 ΔtyrA harboring the plasmid pSaroBtktA This study 
N74dAdEtktA E. coli NST74 ΔtyrA ΔtrpE harboring the plasmid pStktA This study 
N74dAdEaroB E. coli NST74 ΔtyrA ΔtrpE harboring the plasmid pSaroB This study 
N74dAdEaroBtktA E. coli NST74 ΔtyrA ΔtrpE harboring the plasmid pSaroBtktA This study 
N74dASO E. coli NST74 ΔtyrA harboring the plasmids pTpal-fdc and pTKstyAB This study 
N74dAPED E. coli NST74 ΔtyrA harboring the plasmids pTpal-fdc and pTKnah This study 
Plasmids 
pTrc99A Ptrc, pBR322 ori, lacI
q, Ampr Prather Lab, MIT 
pSTV28 Plac, p15A ori, lacI
q, Cmr  Prather Lab, MIT 
pTrcColaK Ptrc, ColA ori, lacI
q, Kanr This study 
pTpal PAL2 of A. thaliana inserted into the NcoI and XbaI sites of pTrc99a This study 
pTpal-fdc FDC1 of S. cerevisiae inserted into the SbfI and HindIII sites of pTpal This study 
pTKxylMA xylMA of P. putida mt-2 inserted into the XbaI and HindIII sites of pTrcColaK This study 
pTKcymAB cymAB of P. putida F1 inserted into the XbaI and HindIII sites of pTrcColaK This study 
pTKstyAB styAB of P. putida S12 inserted into the XbaI and HindIII sites of pTrcColaK This study 
pTKnah nahAaAbAcAd of P. putida NCIB 9816 inserted into the sites of pTrcColaK This study 
pUN15-pal2 Clone U12256 containing AT3G53260 (PAL2) from A. thaliana ABRC 
pStktA tktA of E. coli inserted in the BamHI and SphI sites of pSTV28 This study 
pSaroB aroB of E. coli inserted in the EcoRI and BamHI sites of pSTV28 This study 
pSaroBtktA aroB of E. coli inserted in the EcoRI and BamHI sites of pStktA This study 
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3.2.2 Toxicity assays 
The toxicity effects of (S)-styrene oxide and (R)-1,2-phenylethanediol on E. coli 
were determined by monitoring the impacts of the exogenous addition of increasing final 
concentrations of (S)-styrene oxide or (R)-1,2-phenylethanediol to growing cultures. 
Approximately 1 ml of an E. coli NST74 seed was used to inoculate 50 ml of LB broth in 
a 250 mL shake flask. At the time when the cultures reached an optical density (OD600) of 
~0.6, (S)-styrene oxide and (R)-1,2-phenylethanediol were added to the flasks at an array 
of final concentrations between 0 to 1.8 g/L and 0 to 9 g/L, respectively. Culturing then 
resumed for another 6 h while cell growth, as determined by OD600 measurements, was 
periodically monitored using a UV/Vis spectrophotometer (Beckman Coulter DU800, 
Brea, CA). 
3.2.3 Cloning of PAL2 from A. thaliana, FDC1 from S. cerevisiae, and tktA and aroB 
from E. coli 
All genes were PCR amplified using a BioRad iCycler system, Phusion DNA 
Polymerase (New England Biolabs, Ipswich, MA), and custom oligonucleotide primers 
(see Supplementary Information; note: primer names indicate restriction sites used for 
cloning). PCR cycling and reaction conditions were standardized according to 
manufacturer instructions. All PCR amplified DNA fragments were purified using the 
Zyppy DNA Clean and Concentrator kit (Zymo Research, Irvine, CA). Gene fragments 
and plasmids were treated by endonuclease digestion according to manufacturer’s 
protocols. All digested fragments were first gel purified using the Zyppy DNA 
purification kit (Zymo Research, Irvine, CA) and then ligated with T4 DNA Ligase (New 
England Biolabs, Ipswich, MA) at 4
o
C overnight before the mixture was then 
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transformed into chemically competent E. coli NEB10-Beta. Transformants were selected 
on LB solid agar with appropriate antibiotics and cultured at 37
o
C overnight. 
Transformant pools were screened using colony PCR with final confirmation by gene 
sequencing. PAL2 was amplified from cDNA of clone U12256 from the Arabidopsis 
Biological Resource Center (ABRC, Columbus, OH) and cloned into pTrc99a, resulting 
in construction of the plasmid pTpal. FDC1 was amplified from gDNA of S. cerevisiae 
and cloned into pTpal, resulting in construction of the plasmid pTpal-fdc (Table 3.1). 
Using methods analogous to those described above, tktA and aroB were each PCR 
amplified from gDNA template prepared from E. coli NST74 and cloned into pSTV28. 
These works resulted in the generation of the plasmids pStktA and pSaroB (Table 3.1).  
3.2.4 Construction of the plasmid pTrcColaK and the cloning of SMO- and SDO-
encoding genes  
The plasmid pTrcColaK was constructed by ligating a PCR amplified expression 
cassette from pTrc99a (containing the trc promoter, laqIq repressor, and multi-cloning 
site) together with a PCR amplified fragment from pCOLADuet-1 (EMD Millipore, 
Billerica, MA) containing the ColA origin of replication and kanamycin resistance 
marker.  Using methods analogous to those described above, xylAM, cymA1A2, styAB, 
and nahAaAbAcAd were PCR amplified from gDNA templates from P. putida mt-2, F1, 
S12, and NCIB 9816-4, respectively, and individually cloned into pTrcColaK. These 
works resulted in the generation of the plasmids pTKstyAB, pTKcymAB, pTKxylMA, 
and pTKnah (Table 3.1).  
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3.2.5 Construction of tyrA and trpE deletion mutants in E. coli NST74 
 Chromosomal in-frame gene deletion was accomplished using an approach 
adapted from the methods of Datsenko and Wanner (Datsenko and Wanner 2000). 
Deletion cassettes harboring the kanamycin resistance gene flanked by the FLP 
recognition target sites were PCR amplified from the gDNA of the Keio collection 
mutants E. coli JW2581-1 and JW1256-1 (Baba et al. 2006) for the chromosomal 
integration of tyrA::FRT-Kan-FRT and trpE::FRT-Kan-FRT, respectively. This resulted 
in the construction of the phenylalanine over-producing strains N74dA (NST74 ΔtyrA) 
and N74dAdE (NST74 ΔtyrA ΔtrpE). 
3.2.6 Construction of phenylalanine, (S)-styrene oxide, and (R)-1,2-phenylethanediol 
producing strains  
The previously engineered phenylalanine over-producing strain E. coli NST74 
was individually transformed with pStktA, pSaroB, and pSaroBtktA to generate strains 
NST74tktA, NST74aroB, and NST74aroBtktA, respectively.  E. coli NST74 and N74dA 
were also co-transformed with the plasmids pTpal-fdc and pTKsty or pTKnah resulting in 
strains N74SO, N74PED, N74dASO, and N74dAPED, respectively. Analogous methods 
were used to construct the strains N74dAtktA, N74dAaroB, N74dAaroBtktA, 
N74dAdEtktA, N74dAdEaroB, and N74dAdEaroBtktA (Table 3.1). 
3.2.7 Assaying SMO activity in recombinant E. coli whole resting cells   
The three SMO harboring plasmids were individually transformed into E. coli 
BL21(DE3) to generate strains E. coli BL21:pTKstyAB, E. coli BL21:pTKcymAB, and 
E. coli BL21:pTKxylMA. Shake flasks (250 mL) containing 50 mL of LB with 1%w./v. 
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glucose were inoculated with 1 mL of overnight seed culture. Cultures were grown until 
an OD600 of ~0.6, induced by addition of 0.2 mM IPTG, and then incubated for 6 h before 
an equal number of cells (~0.5 g/L dry cell weight) were collected from each by 
centrifuging at 2000 x g for 5 min. The pellet was washed once with pH 7 PBS 
(phosphate buffered saline) before being re-suspended in 25 ml PBS buffer with 1%w./v. 
glucose (for cofactor regeneration) in a 250 ml shake flask. Finally, 0.22 g/L styrene was 
added to the suspension before sealing the flask. Cultures were shaken at 32°C for 3 h 
and sampled every hour to monitor both styrene depletion and (S)-styrene oxide 
production via HPLC. 
3.2.8 HPLC analysis 
Samples (1 mL) were centrifuged at 11,000 x g for 2 min to pellet cells and 
supernatants (0.75 mL) were then transferred to glass HPLC vials with Teflon-lined caps. 
All HPLC analysis was carried out using a Hewlett Packard 1100 series HPLC system.  
For aromatics analysis, separation was performed on a reverse-phase Hypersil Gold 
SBC18 column (4.6mm x 150 mm; Thermo Fisher, USA) operated at 45
o
C.  The column 
was eluted at a total constant flow rate of 1.0 ml/min using ‘solvent A’ (consisting of 
double-distilled water) and ‘solvent B’ (consisting of methanol (99.8% grade) plus 
0.1%v./v. trifluoroacetic acid (TFA)).  The eluent began as a mixture of 95% solvent A 
and 5% solvent B before a linear gradient was applied over 8 min to then reach a mixture 
of 20% solvent A and 80% solvent B.  This eluent composition was then held constant 
for 2 min before a second linear gradient was then applied over the course of 4 min to 
achieve a final mixture of 95% solvent A and 5% solvent B. The eluent was monitored 
using a diode array detector set at 215 nm for L-phenylalanine, (S)-styrene oxide, and 
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(R)-1,2-phenylethanediol and 258 nm for trans-cinnamate and styrene. Under these 
conditions L-phenylalanine, trans-cinnamate, styrene, (S)-styrene oxide, and (R)-1,2-
phenylethanediol were eluted at 4.3, 9.5, 11.1, 8.2 and 6.0 min, respectively.  Glucose 
analysis was performed on the same HPLC system, however now using an RID detector 
and an anion exchange column (Aminex HPX-87H; BioRAD, Hercules, CA) operated at 
35
o
C. The column was eluted with 0.005 M H2SO4 at a constant flow rate of 0.8 ml/min.  
External calibrations were used to determine concentrations for each analyte.  
3.3 Results and Discussion 
3.3.1 Assessing and investigating the mechanisms of product toxicity 
Prior to investigating their production from glucose, preliminary toxicity screens 
were first performed for both (S)-styrene oxide and (R)-1,2-phenylethanediol to better 
anticipate the effects of their accumulation on E. coli growth. By screening for changes in 
E. coli growth rate and yield under the stress of the added chemicals, toxicity thresholds 
of ~1.6 and ~8 g/L were approximated for (S)-styrene oxide and (R)-1,2-
phenylethanediol, respectively, as shown in Fig. 2A and 2B. While it is certainly 
plausible that exogenous chemical addition does not offer a complete view of cell 
response to their presence relative to when the same compounds are instead synthesized 
endogenously within the cell, experience indicates that, at least in the case of aromatic 
solvents, said approach can provide a reasonable first approximation (McKenna and 
Nielsen 2011).  By this same approach, toxicity limits for the pathway intermediates 
styrene and trans-cinnamate against E. coli were previously approximated as 300 and 800 
mg/L, respectively (McKenna and Nielsen 2011). For many organic solvents, the octanol-
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water partition coefficient (reported as logKO/W) has been found to strongly correlate with 
cytotoxicity, and thus is commonly used as predictor of solvent toxicity towards E. coli 
and other bacteria (Heipieper, Weber, Sikkema, Keweloh, and Debont 1994; Ramos, 
Duque, Gallegos, Godoy, Ramos-Gonzalez, et al. 2002). Thus, with a logKO/W of 1.61 
and 0.92, (S)-styrene oxide and (R)-1,2-phenylethanediol were anticipated to be less toxic 
than both styrene and trans-cinnamate (whose logKO/W value are 3.05 and 2.13, 
respectively), as is consistent with the present findings. 
 
 
Figure 3.2. (S)-styrene oxide and (R)-1,2-phenylethanediol toxicity. A) The effects of 
(S)-styrene oxide to the growth of E. coli cultures as measured by OD600. (S)-Styrene 
oxide was added at final concentrations of 0 (squares), 0.5 (circles), 1 (triangles), 1.2 
(diamonds), 1.4 (open squares), 1.6 (open circles), and 1.8 g/L (open triangles). B) The 
effects of (R)-1,2-phenylethanediol on E. coli cultures when added at final concentrations 
of 0 (squares), 4 (circles), 5 (triangles), 6 (diamonds), 7 (open squares), 8 (open circles), 
and 9 g/L (open triangles). C) A comparison of toxicity versus KM/W  (both relative to n-
butanol as a reference) for several aromatics of interest, including: styrene (open 
triangle), p-hydroxystyrene (solid square), trans-cinnamate (open diamond), (S)-styrene 
oxide (solid star), phenol (solid diamond), 2-phenylacetate (solid circle), 2-phenylethanol 
(solid triangle), n-pentanol (open circle; included as additional reference), (R)-1,2-
phenylethanediol (open square), and n-butanol (solid circle). Error bars reported at one 
standard deviation from triplicate experiments. 
It has been hypothesized that the toxicity of aromatics against E. coli, like many 
other solvents (De Carvalho et al. 2004; Knoshaug and Zhang 2009; Nielsen et al. 2009), 
stems from their proclivity to accumulate in the cytoplasmic membrane, disrupting its 
integrity and ultimately cell function (McKarns et al. 1997; Sardessai and Bhosle 2002). 
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Testing this hypothesis, membrane-water partitioning coefficients (KM/W) were predicted 
for (S)-styrene oxide and (R)-1,2-phenylethanediol, as well as other aromatics that have 
been examined by our group (unpublished data) or for which prior literature reports were 
available (Keweloh, Heipieper, and Rehm 1989; Park, Buehler, et al. 2006), according to 
the model of Sikkema et al. (Sikkema, de Bont, and Poolman 1994):  
                          
Predictions of KM/W for each species, as well as their toxicity thresholds for E. coli, are 
also compared in Fig. 2C.  To provide a frame of reference, however, the results are 
compared relative to the predicted KM/W and previously report toxicity of n-butanol (note: 
E. coli’s n-butanol toxicity limit is ~1%w./v.) (Nielsen et al. 2009; Winkler, Rehmann, 
and Kao 2010), as it is generally accepted that n-butanol’s toxicity arises due to its 
membrane accumulation (Bowles and Ellefson 1985; Osborne et al. 1990). The observed 
strong linear correlation existing between the relative toxicity of aromatics versus their 
predicted relative tendency to accumulate in the membrane provides direct support for the 
hypothesis that membrane accumulation/disruption is the predominant toxicity 
mechanism of aromatics against E. coli.  
3.3.2 Screening and selecting pathway enzymes 
In addition to providing preliminary targets for maximal end-product 
accumulation, these findings further suggest that a high turnover of trans-cinnamate, and 
especially styrene, must be achieved to avoid the inhibitory effects of their intermediate 
accumulation on (S)-styrene oxide and (R)-1,2-phenylethanediol producing strains. 
Furthermore, if this condition can be achieved, it may then also be possible to achieve 
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higher final titers of (S)-styrene oxide and (R)-1,2-phenylethanediol than have been 
previously reported for either styrene or trans-cinnamate under otherwise equivalent 
conditions (McKenna and Nielsen 2011). To achieve this, however, high metabolite flux 
through the entire pathway must be realized, including at the final pathway steps (i.e., 
SMO and SDO).  Thus, identifying a SMO and SDO with the greatest inherent activity in 
E. coli was an important initial aim. Based on previous reports, SMO candidates encoded 
by styAB from P. putida S12, xylMA from P. putida mt-2, and cymA1A2 from P. putida 
F1 were selected for screening and analysis in E. coli. Recombinant SMO activity was 
screened via whole resting cell assays for each of E. coli BL21(DE3) pTKstyAB, E. coli 
BL21(DE3) pTKxylMA, and E. coli BL21(DE3) pTKcymAB.   The results are compared 
in Fig. 3.3, where (S)-styrene oxide production via the biotransformation of exogenously 
supplied styrene was monitored for a period of 3 h. As can be seen, E. coli BL21(DE3) 
pTKstyAB displayed the highest rates of styrene degradation and (S)-styrene oxide 
accumulation, suggesting that StyAB possessed the greatest recombinant activity; 
followed by XylMA from mt-2 then CymA1A2 from F1. These findings are consistent 
with previous reports which found the specific activity of StyAB for styrene to be 180 
U/g (Panke et al. 1998), whereas XylMA (22 U/g (Wubbolts et al. 1994)) and CymA1A2 
(2.30 U/g (Nishio et al. 2001)) were much less active. Furthermore, this result is not 
altogether surprising as styrene is the natural substrate of StyAB, whereas XylMA and 
CymA1A2 only incidentally display SMO activity as a result of their relaxed substrate 
specificities. StyAB was accordingly selected for use in the proposed pathway and in all 
subsequent studies.  Meanwhile, as only a single SDO candidate was identified, the 
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recombinant activity of NahAaAbAcAd was not analogously screened in isolation, but 
instead was directly evaluated in styrene-producing cultures, as described below. 
 
Figure 3.3. SMO activity. Comparing the activity of candidate SMOs in whole resting 
cell assays of E. coli BL21(DE3) (diamonds) individually transformed with the plasmids 
pTKstyAB (triangles), pTKxylMA (squares), and pTKcymAB (circles). Styrene (solid 
symbols) was added at an initial concentration of 0.22 g/L and the accumulation of (S)-
styrene oxide (open symbols) was monitored as a function of time. No styrene 
monooxygenase activity was observed in the E. coli BL21(DE3) background. Error bars 
reported at one standard deviation from triplicate experiments. 
 
3.3.3 Evaluating pathway function and performance 
Having been previously-engineered to overproduce phenylalanine (Tribe 1987) 
and successfully employed as a platform for styrene production (McKenna and Nielsen 
2011), E. coli NST74 was selected as the initial production host for both (S)-styrene 
oxide and (R)-1,2-phenylethanediol. E. coli NST74 was co-transformed with pTpal-fdc 
and pTKstyAB or pTKnah, resulting in strains N74SO and N74PED, respectively.  
Together with NST74, these first generation strains were analogously evaluated. with 
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accumulation of the respective end-products being monitored in each case.  As seen in 
Fig. 3.4, after 72 h, up to 0.97±0.03 g/L (8.08±0.25 mM) of (S)-styrene oxide was 
produced by N74SO at a yield of 0.083±0.005 g/g (0.125±0.008 mol/mol).  N74PED, 
meanwhile, produced 0.41±0.02 g/L (2.95±0.14 mM) (R)-1,2-phenylethanediol at 
0.035±0.002 g/g yield (0.046±0.003 mol/mol).  It should be noted that phenylalanine, 
trans-cinnamate, and styrene were undetectable in these strains at all times, indicating 
rapid turnover of intermediates and efficient flux through the pathway. In comparison, 
phenylalanine production by NST74 reached up to 1.1±0.03 g/L (6.66±0.18 mM) at a 
yield of 0.095±0.005 g/g (0.104±0.008 mol/mol), or 25% of theoretical. Relative to 
phenylalanine, it is hypothesized that higher molar titers and yields of (S)-styrene oxide 
resulted due to the rapid turnover of phenylalanine by StyAB, which in turn increased 
flux through the amino acid biosynthesis pathway.  By this logic, the relatively lower 
titers and yields of (R)-1,2-phenylethanediol by N74PED could perhaps have stemmed 
from low SDO activity displayed by NahAaAbAcAd.  If this is the case, identifying or 
engineering for more active SDO isoenzymes could result in future improvements. A 
BlastP search based on NahAaAbAcAd reveals several additional, four-subunit candidate 
dioxygenases from Pseudomonas sp. (including P. fluorescens, P. stutzeri, P. 
chlororaphis, P. xanthomarina, P. monteilii, P. balearica), as well as one from Rhanella 
sp. LCY15.  Whereas all are similarly classified as naphthalene dioxygenases, their future 
screening could lead to the identification of more robust enzyme ‘parts’ for the (R)-1,2-
phenylethanediol pathway. 
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Figure 3.4. Comparing phenylalanine, (S)-styrene oxide, and (R)-1,2-
phenylethanediol titers after 24 (gray), 48 (diagonals), and 72 h (hashed) by strains 
NST74, N74SO, and N74PED and the tyrosine auxotrophs N74dA, N74dASO, and 
N74dAPED, respectively. Note that additional accumulation of phenylalanine, trans-
cinnamate, or styrene was undetected at all times in all N74SO, N74PED, N74dASO, and 
N74dAPED cultures. Error bars reported at one standard deviation from triplicate 
experiments. 
3.3.4 Promoting availability of phenylalanine, the pathway precursor 
As maximum titers remained below their anticipated inhibitory thresholds and no 
excess phenylalanine was detectable in N74SO and N74PED cultures, it was 
hypothesized that biosynthesis of the phenylalanine precursor was perhaps the 
predominant limiting factor in our pathways and strains. Thus, multiple strategies were 
systematically investigated to improve endogenous phenylalanine production by the host 
strain.  As seen in Fig. 3.1, the first step of the shikimic acid pathway consists of the 
condensation of phosphoenolpyruvate (PEP; derived via glycolysis) and erythrose 4-
phosphate (E4P; derived via the pentose phosphate pathway) to yield 3-deoxy-D-arabino-
heptulosonate-7-phophate (DAHP). Although DAHP synthase has already been 
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effectively feedback-deregulated in E. coli NST74, it has been shown that this initial 
condensation step is typically limited by low E4P availability. As such, overexpression of 
transketolase I (TktA) promotes increased E4P production (Gosset, Yong-Xiao, and Berry 
1996; Kambourakis, Draths, and Frost 2000; Draths et al. 1992). Also reported, flux through 
the shikimic acid pathway is improved by preventing DAHP accumulation, as achieved 
by overexpressing 3-dehydroquinate synthase (AroB) (Kambourakis, Draths, and Frost 2000; 
Keseler et al. 2005). Meanwhile, in addition to serving as a precursor to phenylalanine, 
chorismate is also the key branch point metabolite from which all other aromatic amino 
acids, namely tryptophan (via anthranilate synthase; TrpED) and tyrosine (following its 
conversion to prephenate via chorismate dehydratase; TyrA). While trpE and tyrA 
deletion will lead to tryptophan and tyrosine auxotrophies (necessitating their 
supplementation to cultures), said mutations will enable an assessment of maximum 
achievable production levels by our strains. The individual and combined effects of these 
strategies on phenylalanine production were next investigated with the goal of developing 
a more robust host. As seen in Fig. 3.5, relative to NST74, deletion of tyrA (N74dA) led 
to a 1.5-fold increase in phenylalanine production after 72 h at a similar yield, whereas 
the additional deletion of trpE (N74dAdE) actually negated this improvement. Then, by 
combining tyrA deletion with tktA overexpression (N74dAtktA), phenylalanine titer and 
yield were each improved by >50%, reaching 37% of the theoretical yield. However, tktA 
overexpression also imposed a marked negative effect on cell growth, causing an initial 
lag period that lasted nearly 16 h (data not shown). The impact on phenylalanine 
production too is seen in Fig. 3.5, where titers at 24 h are lowest for tktA overexpressing 
strains. In contrast, tyrA deletion rendered no impact on cell growth (data not shown). 
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Meanwhile, overexpression of aroB, either alone or in combination, provided no 
significant impact. N74dA and N74dAtktA were accordingly selected for further 
evaluation as hosts for (S)-styrene oxide and (R)-1,2-phenylethanediol production upon 
pathway introduction.  
 
Figure 3.5 Phenylalanine titers. Comparing phenylalanine titers after 24 (gray), 48 
(diagonals), and 72 h (hashed).  Inset table shows final (72 h) phenylalanine yields on 
glucose (g/g). The maximum theoretical phenylalanine yield from glucose is 0.55 g/g 
(Juminaga et al. 2012). Error bars reported at one standard deviation from triplicate 
experiments. 
3.3.5 Improving production using more robust host strains 
Despite producing the most phenylalanine, with N74dAtktA as host both (S)-
styrene oxide and (R)-1,2-phenylethanediol titers were greatly reduced, reaching only 
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0.62±0.07 g/L and 0.32±0.02 g/L, respectively.  This was likely due to the compromised 
fitness of this strain, as indicated by its poor growth phenotype (noted above), which may 
have been further exacerbated by the increased burden associated with introducing the 
pathway plasmids. In contrast, with N74dA as host (S)-styrene oxide and (R)-1,2-
phenylethanediol production was greatly improved (Fig. 3.4). Relative to N74SO, (S)-
styrene oxide production by N74dASO was improved by ~30%, to a final titer of 
1.32±0.03 g/L (11.0±0.25 mM) at a yield of 0.115±0.005 g/g (0.172±0.007 mol/mol) or 
39% of theoretical, and now approaches its estimated toxicity limit (~1.6 g/L). However, 
with a final titer of 1.23±0.07 g/L (8.9±0.51 mM) and a yield of 0.109±0.002 g/g 
(0.142±0.003 mol/mol) or 32% of theoretical, a more striking difference, was the ~3-fold 
increase in (R)-1,2-phenylethanediol production by N74dAPED (relative to N74PED).   
Another important outcome of this study is the demonstration that enhanced flux 
through the styrene pathway can be realized if styrene’s toxic effects can be addressed or 
overcome, as was achieved in this case by its in vivo transformation to a less toxic 
product, namely (S)-styrene oxide or (R)-1,2-phenylethanediol. For example, under 
analogous conditions, prior works have shown that E. coli can produce up to 260±4.31 
mg/L (2.5±0.04 mM) styrene before reaching its toxicity limit, representing a yield of 
0.07 g/g (0.12 mol/mol) or 27% of its theoretical maximum (McKenna and Nielsen 
2011). However, by simply extending the styrene pathway by one step to efficiently 
convert styrene to (S)-styrene oxide, for example, net flux through the pathway was 
increased by 4.4-fold while the yield was improved by over 40%.  Though slightly less 
dramatic, the same is also true of (R)-1,2-phenylethanediol production. Thus, as styrene is 
the precursor to both (S)-styrene oxide and (R)-1,2-phenylethanediol, these findings also 
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imply that it is possible for the molar flux to styrene in E. coli to reach at least these 
levels. This realization provides important motivation to the continued development of 
the styrene pathway, and the development of styrene tolerant microbes as platforms to 
produce this important monomer at high levels from renewable resources.   
3.4 Conclusion 
 A novel method for the direct production of the chiral aromatic building blocks 
(S)-styrene oxide and (R)-1,2-phenylethanediol from renewable glucose has been 
established. While initial experiments demonstrated that low availability of precursor 
phenylalanine limited production of both compounds, a systematic approach towards 
enhancing flux through the phenylalanine biosynthesis pathway ultimately resulted in the 
improved bioproduction of both (S)-styrene oxide and (R)-1,2-phenylethanediol. Toxicity 
of both compounds was strongly correlated with a model of membrane accumulation and 
disruption, and was likely a limiting factor in the case of (S)-styrene oxide.  These works 
demonstrate the versatility of the styrene pathway as a platform for producing other 
useful and valuable aromatic fine chemicals, and show that greater flux through the 
styrene pathway is possible if styrene’s toxicity can first be effectively addressed. 
65 
 
CHAPTER 4 
ENGINEERING THE STYRENE PATHWAY IN YEAST 
Abstract 
Here we report the first heterologous production of styrene in yeast from glucose. 
This was achieved from the native aromatic amino acid phenylalanine in a two-step 
biosynthetic pathway by expressing the phenylalanine ammonia lyase PAL2 from 
Arabidopsis thaliana and the ferulate decarboxylase FDC1, which is native to 
Saccharomyces cerevisiae. A phenylalanine overproducing strain of S. cerevisiae was 
first engineered via EMS mutagenesis and selection on antimetabolites resulting in a 
strain capable of producing 357±32.5 mg/L phenylalanine. This strain, 22A74D, was 
further engineered to knockout the Ehrlich pathway (ΔARO10) and to incorporate the 
feedback-resistant DAHP synthase ARO4
K229L
. After expressing PAL2 and relying on 
native expression of FDC1, styrene titers reached 28.8±2.1 mg/L. 
4.1 Introduction 
Like most monomers used in conventional plastics production, at present, all 
commercially-available styrene is solely derived from non-renewable petroleum 
feedstocks. More specifically, the predominant means by which styrene is synthesized is 
the chemocatalytic dehydrogenation of petroleum-derived ethylbenzene (Wu, Koylinski, 
and Bozik 1981; Mimura and Saito 2000). With the global annual demand of styrene to 
surpass 41 million tons by 2020 (James and Castor 2011) (a >$28 billion U.S. 
market(SRI 2010)), the net energy requirements for just this single transformation step 
amount to over 200 trillion BTU of steam each year (DoE 2002). However, driven by 
concerns over depleting feedstock availability and deleterious environmental impacts, 
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there is growing interest in the development of  ‘green’ processes for the production of 
biorenewable replacements to conventional petroleum products, including numerous 
monomers and plastics.   
Advances in metabolic and pathway engineering have been paramount to the 
continuously expanding range of conventional monomer compounds that can now be 
synthesized from renewable biomass feedstocks (Adkins et al. 2012; Curran and Alper 
2012; Erickson, Nelson, and Winters 2012; Lee et al. 2011). Along these lines, in prior 
works a novel and non-natural pathway for styrene biosynthesis from biomass-derived 
glucose was recently engineered in the bacterium Escherichia coli (McKenna and Nielsen 
2011). The previously-engineered pathway, depicted in Fig. 4.1, utilizes phenylalanine, a 
naturally occurring proteinogenic amino acid, as its precursor (McKenna and Nielsen 
2011). Phenylalanine is first deaminated to trans-cinnamate by phenylalanine ammonia 
lyase (PAL). It was found that PAL2 from Arabidopsis thaliana displays both the greatest 
activity and highest substrate specificity (i.e., for phenylalanine) when recombinantly 
expressed in E. coli (McKenna and Nielsen 2011). Next, trans-cinnamate is 
decarboxylated to styrene via the expression of the phenylacrylate decarboxylase FDC1 
(originally characterized as a ferulate decarboxylase) from Saccharomyces cerevisiae 
(McKenna and Nielsen 2011; Mukai et al. 2010). When PAL2 and FDC1 were 
subsequently co-expressed in a previously-engineered L-phenylalanine over-producing E. 
coli background grown in glucose minimal media, the resultant styrene titers reached 
~260 mg/L in 29 h at a yield of about 0.030 g/g (McKenna and Nielsen 2011). As E. coli 
was found to possess a low toxicity threshold for styrene (between only 200 to 300 
mg/L), this suggested that end-product toxicity (likely caused by membrane 
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accumulation/disruption (McKenna et al. 2013)) was the principal limiting factor 
(McKenna and Nielsen 2011).   
As sensitivity to solvent-like products – including, for example, n-
butanol(Atsumi, Hanai, and Liao 2008) and (S)-styrene oxide(McKenna et al. 2013), and 
2-pentanone(Lan et al. 2013),– commonly arises as a productivity-limiting factor in E. 
coli, engineering more robust hosts for renewable chemical production is an important 
aim in industrial biotechnology. Relative to E. coli, the yeast biosynthetic platforms can 
offer several inherent advantages of importance to robust and large–scale renewable 
chemicals production. The most significant of these attributes often includes: faster 
growth rates, elevated solvent tolerance, and the ability to withstand low temperatures 
and pH (Demain and Vaishnav 2009; Sudbery 1996; Curran et al. 2013; Nevoigt 2008; 
Ostergaard, Olsson, and Nielsen 2000). Among yeast, S. cerevisiae is particularly 
attractive for metabolic engineering studies due to its well characterized genetics, 
physiology, and metabolism, as well as the plethora of diverse genetic toolkits for the 
stable expression and introduction of heterologous enzymes and pathways (Alberti, 
Gitler, and Lindquist 2007).  
With an eye towards evaluating and ultimately improving the prospects of 
industrial scale renewable styrene production, the objective of the present study was to 
engineer the yeast S. cerevisiae to synthesize styrene from glucose. In addition to the 
promising phenotypic traits previously mentioned, several additional and complementary 
factors were further responsible for motivating this specific aim. First, past studies have 
shown that S. cerevisiae is a suitable host for the engineering of other, non-native 
aromatic biosynthesis pathways, including for the production of protocatechuate, 
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catechol, vanillin, naringenin, and 2-phenylethanol, among others (Curran et al. 2013; 
Hansen et al. 2009; Jiang, Wood, and Morgan 2005; Stark et al. 2002). Second, in 
addition to displaying general solvent tolerance (Matsui et al. 2008; Kawamoto, Kanda, 
and Tanaka 2001), S. cerevisiae has specifically been shown to display elevated tolerance 
to aromatics such as 2-phenylethanol (Etschmann et al. 2002). Third, it was hypothesized 
that improved function of styrene pathway enzymes might be achieved in S. cerevisiae 
since: i) PAL2 is of eukaryotic origin, and ii) FDC1 is native to S. cerevisiae. Contingent 
upon the native regulation of FDC1 (to be addressed later in this study) this suggests that 
a functional pathway could be in fact constructed via the expression of a single 
heterologous enzyme, thus minimizing the prospects of metabolic burden. Lastly, S. 
cerevisiae does not naturally possess the transporter required for phenylalanine efflux. 
For example, in previous works it has been shown that although intracellular 
concentrations of phenylalanine in S. cerevisiae exceeded 60 mM, its content in the 
associated supernatant was undetectable (Luttik et al. 2008). Retaining phenylalanine 
intracellularly may enhance its availability to the styrene pathway.   
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Figure 4.1 Styrene biosynthesis by S. cerevisiae. Multiple arrows signify that multiple 
steps are occurring but are not illustrated. The dotted arrow represents heterologous gene 
expression of PAL2. Dotted lines from the aromatic amino acids indicate feedback-
repression via transcriptional regulation or allosteric enzyme inhibition, or both. 
Metabolite abbreviations: phosphoenolpyruvate (PEP), erythrose-4-phosphate (E-4P), 3-
deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), hydroxyphenylpyruvate (HPP), 
phenylacetaldehyde (PAA).   
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4.2 Materials and Methods   
4.2.1 Strains and media.  
 All strains and plasmids used in this study are listed in Table 4.1. Custom 
oligonucleotide primers were synthesized by Integrated DNA Technologies (Coralville, 
IA) and presented in the supplementary material. All S. cerevisiae strains were purchased 
from Thermo Scientific (Waltham, MA). Yeast plasmids used were derived from the 
Gateway vector collection and purchased from AddGene (Cambridge, MA). Genomic 
DNA was prepared from whole cells using the ZR Fungal/Bacterial DNA MiniPrep 
(Zymo Research, Irvine, CA) according to vendor protocols.  E. coli strain NEB10β 
(New England Biolabs, Ipswich, MA) was used for all cloning and plasmid propagation, 
except for pDONR221 which was propagated in One Shot ccdB Survival 2 T1 E. coli 
(Life Technologies, Grand Island, NY). E. coli strains were routinely cultured at 37ºC in 
Luria-Bertani (LB) broth (supplemented with appropriate antibiotics, as necessary). Yeast 
strains were routinely cultured at 32ºC in Yeast Extract Peptone Dextrose (YPD) 
medium, yeast synthetic dextrose (SD) medium, or yeast synthetic minimal (SD-Leu) 
medium. YPD medium was composed of of 10 g/L yeast extract, 20 g/L peptone, and 20 
g/L glucose. SD medium was composed of 6.7 g/L yeast nitrogen base, 20 g/L glucose, 
and 20 mg/L of each Uracil, Histidine, Leucine, and Methionine. SD-Leu medium was 
composed of 6.7 g/L yeast nitrogen base, 20 g/L glucose, 20 mg/L each Uracil, Histidine, 
and Methionine. 
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Table 4.1. List of strains and plasmids. 
Strain  Genotype  Source 
E. coli NEB-10 beta 
araD139 ∆(ara,leu)7697 fhuA lacX74 galK16 galE15 mcrA 
f80d(lacZ∆M15)recA1 relA1 endA1 nupG rpsL rph 
spoT1∆(mrr-hsdRMS-mcrBC) 
New England 
Biolabs 
One Shot ccdB 
Survival 2 T1 E. coli 
F
-
mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 araΔ139 Δ(ara-leu)7697galU galK rpsL 
(Str
R
) endA1 nupG fhuA::IS2 
Life Technologies 
BY4741 MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 Thermo Scientific 
BY4741ΔFDC1 
(YDR539W) 
MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0 fdc1Δ Thermo Scientific 
BY4741-PAL MATa his3Δ0 leu2Δ0 met15Δ0 ura3Δ0-425GPDPAL This Study 
22A75D BY4741 phenylalanine overproducer This Study 
22A75D-PAL 22A75D-425GPDPAL This Study 
22A75D10-PAL 22A75D aro10Δ-425GPDPAL This Study 
22A75D104-PAL 22A75D aro10Δ::aro4K229L-425GPDPAL This Study 
Plasmids 
pTrc99A Ptrc, pBR322 ori, lacI
q
, Amp
R
 Prather Lab, MIT 
pFA6-KanMX KanR2, pBR322 ori, Amp
R
  AddGene 
pDONR221 attP1-ccdB-Cm
R
-attP2 cassette, pUC ori, Kan
R
  Life Technologies 
pDONR-PAL PAL2 from A. thaliana inserted into pDONR221 This study 
425GPD 
PGPD, attR1-ccdB-Cm
R
-attR2 cassette, pBR322 ori, LEU2, 
Amp
R
 AddGene 
425GPDPAL PAL2 from A. thaliana inserted into 425GPD This study 
pACYCDuet-1 PT7, p15A ori, lacI
q
, Cm
R
 Novagen 
pACYC- ARO4
K229L
-
KanMX pACYC with the integration cassette aro4
K229L
-KanMX This Study 
pUN15-PAL2 
Clone U12256 containing AT3G53260 (PAL2) from A. 
thaliana ABRC 
 
 4.2.2 Toxicity assays.   
To determine impact of styrene on S. cerevisiae growth, the effect of its 
exogenous addition to growing cultures at increasing final concentrations was 
investigated. Seed cultures of S. cerevisiae BY4741 were prepared in 5 mL of YPD broth 
and grown at 32
o
C overnight while shaking at 250 rpm. The seed culture (1 ml) was then 
used to inoculate 50 ml of YPD broth in a 250 mL shake flask. Cultures were grown to an 
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optical density at 600 nm (OD600) of ~0.6, at which time styrene was added to the flasks 
at an array of final concentrations ranging between 0 to 1 g/L. Culturing resumed at 32
o
C 
for an additional 6-8 h while cell growth, as determined by OD600 measurements, was 
periodically monitored using a UV/Vis spectrophotometer (DU800, Beckman Coulter, 
Brea, CA). 
4.2.3 Evolution of phenylalanine overproducing strains.  
Evolution of a phenylalanine over-producing phenotype in S. cerevisiae was 
achieved through random mutagenesis and high-throughput selection using the 
phenylalanine anti-metabolite m-fluoro-DL-phenylalanine to provide selective pressure. 
S. cerevisiae BY4741 was first treated with ethylmethanesulphonate (EMS) according to 
standard protocols(Winston 2001) before then being plated on minimal media 
supplemented with m-fluoro-DL-phenylalanine. In the first round of mutagenesis, 
selection occurred on SD media plates supplemented with either 18 or 22 mg/L m-fluoro-
DL-phenylalanine. Note that the BY4741’s minimum inhibitory concentration of m-
fluoro-DL-phenylalanine was previously found to be approximately 15 mg/L (data not 
shown). Two mutants (designated 18A and 22A) were subsequently isolated from the 
first round of mutagenesis before then being cultured in SD media for 48 h at 32
o
C. 
Supernatants were analyzed by high performance liquid chromatography (HPLC; as 
described below) to test for their comparative ability to produce 2-phenylethanol. Note 
that 2-phenylethanol, which is endogenously produced from phenylpyruvate via ARO10, 
was used as a surrogate to indicate phenylalanine over-production because phenylalanine 
is not exported to the extracellular media(Luttik et al. 2008). Strains 18A and 22A were 
then subjected to a second round of mutagenesis as preformed above, however, in this 
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case the resultant mutants were selected for on SD media plates supplemented with 25, 
50, or 75 mg/L m-fluoro-DL-phenylalanine. From this, 18 mutants were then isolated 
before then being similarly cultured and characterized with respect to their 2-
phenylethanol production abilities. The key regulatory genes (as well as 500 bp upstream 
of the start codon) of the phenylalanine pathway ARO3, ARO4, ARO7, ARO8, GCN4, and 
PHA2 were sequenced in the strains BY4741, 22A, and 22A75D. 
4.2.4 Transcriptional analysis of phenylalanine over-producing mutants.  
Relative transcription levels of each of ARO1, ARO2, ARO3, ARO4, ARO7, 
ARO8, ARO9, and PHA2 were quantified at mid-log phase in the strains BY4741, 22A, 
and 22A75D. Approximately 1.5×10
8 
cells of each strain were collected by centrifugation 
at 17,000 x g for 1 min. The supernatant was discarded and RNA was extracted from the 
cell pellet using the YeaStar RNA Extraction Kit (Zymo Research, Irvine, CA). cDNA 
was synthesized using the SuperScript VILO cDNA Synthesis Kit (Life Technologies) 
and RT-qPCR was performed using SYBR Green (Life Technologies) based quantitative 
PCR according to manufacturer’s protocols. Custom oligonucleotide primers for RT-
qPCR experiments, including those for the reference housekeeping gene 26S (Martorell, 
Querol, and Fernández-Espinar 2005), were designed and synthesized, the sequences of 
which are provided in Table S1 (see Supplementary Information). RT-qPCR was 
performed on an Applied Biosystems StepOne Real-Time PCR (Applied Biosystems) 
using a 60ºC annealing temperature. Data analysis was performed using StepOne 
software and relative transcriptional levels were calculated using the 2
-ΔΔCt
 method(Livak 
and Schmittgen 2001). 
4.2.5 Investigating native expression and activity of FDC1 in S. cerevisiae.  
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 S. cerevisiae BY4741 seed cultures were prepared (in triplicate) in 5 mL YPD 
broth and cultured at 32°C while shaking at 250 rpm overnight. 1 ml of each seed was 
then used to again inoculate 50 ml SD media. These cultures were grown until reaching 
an OD600 of ~0.6, at which point each was induced by either trans-cinnamate, ferulic 
acid, p-coumaric acid, or phenylalanine at a final concentration of 0.2 mM. Induced 
cultures were incubated for an additional 12 h after which an equal number of cells 
(OD600 = 4) were collected by centrifugation at 2800 x g for 4 min. Cells were lysed using 
Zymolyase (Zymo Research) and the supernatant collected after centrifugation at 11,000 
x g for 2 min. FDC1 activity was assayed at room temperature in pH 7.5 50 mM Tris-HCl 
buffer containing 250 mM trans-cinnamate, and initiated by the addition of 5 µL of crude 
cell lysate. The accumulation of styrene was then followed at 247 nm on a UV/Vis 
Spectrophotometer for a total of 5 min at 20 sec intervals. A molar extinction coefficient 
of 10,000 M
-1
 cm
-1
 and a 1 cm path length were used to establish enzyme activity in 
terms of U mg
-1
 total protein. The total protein content in each lysate sample was 
determined by Bradford Assay using bovine serum albumin (BSA) as an external 
standard. 
4.2.6 Cloning of PAL2 from A. thaliana.   
The PAL2 encoding gene from A. thaliana was derived from cDNA library 
plasmids containing the specific loci of interest (Table 4.1) obtained from the 
Arabidopsis Biological Research Center (ABRC; Ohio State University, Columbus, OH). 
PAL2 was PCR amplified using Phusion DNA Polymerase (Finnzymes, Espoo, Finland) 
using custom oligonucleotide primers (supplementary material). Using Gateway Cloning 
Technology (Alberti, Gitler, and Lindquist 2007), amplified linear DNA fragments 
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flanked with attB sequences were purified using the Zyppy Clean and Concentrator kit 
(Zymo Research). The BP reaction between the DNA fragment and pDONR221 (Life 
Technologies) was created using Gateway BP Clonase II Enzyme Mix (Life 
Technologies) following manufacturer’s protocols. Transformants were selected by 
plating on LB solid agar containing kanamycin and culturing at 37
o
C overnight. The 
resultant donor plasmid, pDONR-PAL, was mixed with the desired destination plasmid, 
425-GPD, using the Gateway LR Clonase II Enzyme Mix (Life Technologies). 
Transformants were selected by plating on LB solid agar containing ampicillin and 
confirmed using colony PCR. This approach resulted in construction of the constitutively 
induced, high copy number (2µ) plasmid 425GPDPAL, as listed in Table 4.1. 
4.2.7 Assaying the extracellular transport of trans-cinnamate.   
S. cerevisiae BY4741 and the FDC1 knockout mutant BY4741ΔFDC1 
(YDR539W, clone 5834 (Thermo Scientific, Waltham, MA)) were each transformed with 
plasmid 425GPDPAL. Cultures grown in SD-Leu media supplemented with 200 mg/L 
phenylalanine while the extracellular accumulation of trans-cinnamate, styrene, and 2-
phenylethanol were periodically monitored via HPLC over the course of 24 h. 
4.2.8 Chromosomal disruption of ARO10 and integration of ARO4
K229L
.  
Targeted chromosomal disruption of ARO10 in strain 22A75D was performed via 
homologous recombination. Gene disruption cassettes were generated via PCR to contain 
40 base pairs of homology on both sides of the targeted integration site (i.e., ARO10) in 
addition to the KanMX selectable marker (as obtained from pFA6-KanMX4). Following 
transformation, colonies were selected on YPD solid agar plates containing 200 mg/L 
G418. Clones carrying the successful ARO10 disruption cassette were further confirmed 
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by PCR. This resulted in the strain 22A75D10. In addition, a copy of the feedback 
resistant mutant ARO4
K229L
, whose expression was driven by the native ARO4 promoter, 
was likewise integrated into 22A75D at the ARO10 locus, thereby also and 
simultaneously resulting in its chromosomal disruption. In this case, however, the gene 
disruption cassette was first constructed in the E. coli expression vector pACYCDuet-1. 
The ARO4 point mutation (K229L) was generated (and confirmed by sequencing) via 
overlap extension using the primers listed in Table S1 and inserted into the BamHI and 
EcoRI sites of pACYCDuet-1. Subsequently, the KanMX selectable marker together with 
its promoter was inserted downstream of ARO4
K229L
 to generate the plasmid pACYC-
ARO4
K229L
-KanMX. The entire cassette was then PCR amplified using primers whose 
overhangs each contained 40 base pairs of homology to ARO10.  The resultant fragment 
was then transformed into 22A74D as described above, resulting in the strain 
22A75D104.  
4.2.9 Styrene production from glucose in S. cerevisiae shake flask cultures.   
Each of the S. cerevisiae strains BY4741, 22A75D, 22A75D10, and 22A75D104 
were individually transformed with the plasmid 425GPDPAL. The transformants were 
each grown in 5 mL SD-Leu broth for 12 h at 32°C while shaking at 250 rpm to prepare 
seed cultures. Each seed (1 mL) was then used to inoculate 50 mL SD-Leu media in 250 
ml shake flask fitted with a glass cap. A closed system with large headspace was used to 
avoid volatile product (i.e., styrene) losses while also precluding the exhaustion of 
oxygen. Culturing continued for 48 h while 1 ml samples were periodically taken for 
analysis of cell growth and metabolite production. 
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4.2.10 Metabolite analysis.   
Samples were prepared for metabolite analysis via HPLC by first removing 1 mL 
of culture from a shake flask culture and pelleting the cells at 11,000 x g for 2 min.  The 
supernatant (0.75 mL) was then transferred to a glass HPLC vial and sealed with a 
Teflon-lined cap. Analysis was carried out using a Hewlett Packard 1100 series HPLC 
system (Palo Alto, CA) equipped with an auto sampler, diode array (UV/Vis) detector, 
and reverse-phase Hypersil Gold SBC18 column (4.6mm x 150 mm; Thermo Fisher, 
USA). Samples (5 µL) were injected for analysis according to the methods of McKenna 
and Nielsen(McKenna and Nielsen 2011). The eluent was monitored at 215 nm for L-
phenylalanine and 2-phenylethanol and 258 nm for trans-cinnamate and styrene. Under 
these conditions L-phenylalanine, 2-phenylethanol, trans-cinnamate, and styrene were 
eluted at 4.5, 7.1, 8.67, and 10.4 min, respectively. 
4.3 Results 
4.3.1 Assaying styrene toxicity 
 To assess if S. cerevisiae BY4741 would indeed be a suitable host for styrene 
production, a cursory evaluation of its ability to tolerate exogenous styrene at increasing 
concentrations was first performed. Due to its hydrophobic nature, styrene readily 
accumulates within the hydrophobic core of the membrane lipid-bilayer(Juan L. Ramos 
2002; Heipieper, Weber, Sikkema, Keweloh, and de Bont 1994; Isken and de Bont 1998; 
McKenna et al. 2013).   
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Figure 4.2. Toxicity of exogenous styrene against S. cerevisiae BY4741 growing 
cells. Growth response of S. cerevisiae BY4741 to styrene added at final concentrations 
of 0 mg/L (solid square), 200 mg/L (solid circle), 400 mg/L (solid triangle), 600 mg/L 
(open square), 800 mg/L (open circle), and 1000 mg/L (open triangle). Error bars 
reported at one standard deviation from triplicate experiments. 
 
As illustrated in Fig. 4.2, although growth rates and biomass yields were reduced as a 
function of added styrene concentration, growth of BY4741 was still possible up to 400 
mg/L. At 600 mg/L and above, however, no growth was observed following styrene 
addition, suggesting that the toxicity limit exists between 400-600 mg/L.  Although still 
relatively low, this represents a ~2-fold improvement over that of E. coli (McKenna and 
Nielsen 2011). Most importantly, for the purposes of this initial study, these results 
suggest that styrene accumulation to appreciable levels is at least possible in S. 
cerevisiae.  For longer-term applications, however, it is expected that the development or 
discovery of an industrial yeast strain with an improved solvent tolerance phenotype over 
BY4741 (a laboratory strain) will be required for robust styrene bioproduction. 
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4.3.2 Evolving and engineering phenylalanine over-production in S. cerevisiae 
As phenylalanine serves as the immediate endogenous pathway precursor, 
development of a phenylalanine over-production phenotype in S. cerevisiae is an 
essential pre-requisite to styrene biosynthesis. The native aromatic amino acid 
biosynthesis pathways of S. cerevisiae are shown in Fig. 4.1, wherein it can be seen that 
two principal control points must be deregulated to promote increased metabolite flux 
toward phenylalanine. The first, DAHP synthase (ARO3 and ARO4), is allosterically 
feedback inhibited by phenylalanine and tyrosine, respectively (Caspi et al. 2006; Fukuda 
et al. 1991; Teshiba et al. 1986). The second, meanwhile, occurs at the chorismate branch 
point where chorismate mutase (ARO7) converts chorismate to prephenate (the 
intermediate precursor to phenylalanine and tyrosine), but ARO7 is inhibited by as little 
as 0.5 mM tyrosine (Schmidheini et al. 1989; Caspi et al. 2006; Kradolfer et al. 1977).  
 
Figure 4.3. Evolution of phenylalanine overproducing mutants of S. cerevisiae. 
Mutants were evolved through the use of EMS mutagenesis and high-throughput 
selection on anti-metabolite plates. Mutants were grown in SD media and phenylalanine 
production was analyzed after 48 h by measuring the concentration of 2-phenylethanol in 
the supernatant. Error bars reported at one standard deviation from triplicate experiments. 
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To overcome feedback resistance in the phenylalanine biosynthesis pathways, the 
use of antimetabolites, in this case m-fluoro-DL-phenylalanine, in parallel with EMS 
mutagenesis provided the needed selection pressure for evolving phenylalanine over-
producing mutants(Drake 1976). Two mutants were isolated from the first round of 
selection on SD plates containing 18 mg/L (strain 18A) and 22 mg/L (strain 22A) m-
fluoro-DL-phenylalanine. Both mutants were subsequently tested for their respective 
phenylalanine production capacities in shake flask cultures (Fig.4.3). As phenylalanine is 
not exported from S. cerevisiae, the extracellular accumulation of 2-phenylethanol, which 
is naturally and readily produced as a degradation product of phenylpyruvate (the 
precursor to phenylalanine; Fig. 4.1), was used as a measure of increased flux through the 
phenylalanine biosynthesis pathway. 18A and 22A showed 3.3- and 6.4-fold 
improvements in phenylalanine production potential (57.24±5.20 and 109.56±9.24 
mg/L), respectively, relative to the parent control (BY4741).   
A second round of mutagenesis and selection was performed with the objective of 
further deregulating phenylalanine biosynthesis. In this case, the isolated mutants 18A 
and 22A were themselves subjected to further mutagenesis where the selective pressure 
was elevated by application of m-fluoro-DL-phenylalanine at increased concentrations 
(namely 25 mg/L, 50 mg/L, or 75 mg/L). In contrast to the first round, this second round 
of mutagenesis netted numerous colonies (over 50) at all three selection pressures. Thus, 
to screen for the best performers, only the fastest growing mutants were selected (in this 
case, a total of 18) and subsequently tested for their ability to overproduce phenylalanine. 
Amongst the pools, the top performing mutant, named 22A75D, was able to produce an 
estimated 357±32.5 mg/L of phenylalanine in 48 h, representing a ~21-fold improvement 
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over BY4741. The performance of mutant 22A75D was followed closely by 22A75I, 
which was able to produce up to 342±28.9 mg/L phenylalanine.   
In an effort to better understand the genetic bases responsible for the evolved 
phenylalanine over-production phenotype in the most productive mutant (22A75D), key 
genes (as well as 500 bp upstream of the start codon) involved in the phenylalanine 
biosynthesis pathway were sequenced and compared with those of its parent (22A) and 
the control (BY4741). The subset of genes of interest included those associated with the 
known bottleneck enzymes DAHP synthase (ARO3 and ARO4) and chorismate mutase 
(ARO7), as well as phenylalanine prephenate dehydratase (PHA2), aromatic 
aminotransferase (ARO8), and the activator protein GCN4, a transcriptional activator 
involved in the expression of all steps in the phenylalanine biosynthesis pathway (Caspi 
et al. 2006). Interestingly, however, no mutations were observed in any of the genes 
investigated, or in their associated upstream sequences. It is possible, perhaps, that a 
global transcription factor was the cause of the increase rather than single point mutations 
in the individual phenylalanine pathways genes themselves. As no changes in any open 
reading frame tested were detected, this would imply that the evolved phenotype was not 
accrued as a result of relieving allosteric inhibition.  
Accordingly, attention was next directed towards understanding if it were instead 
transcriptional changes that were responsible for the observed phenotypic changes. 
Changes in the transcription level of each of the genes of interest were measured with the 
use of RT-qPCR, and quantified relative to that of the wild-type control (BY4741). As 
illustrated in Fig. 4.4, in 22A75D up-regulation of ARO8 was found to be most 
significant (a 9.3-fold increase), followed by ARO1 (6.8-fold), ARO2 (5.8-fold), and 
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ARO3 (4.5-fold). It is possible that up-regulation of ARO8 was necessary to compete 
with the ARO10 (converts phenylpyruvate to phenylacetaldehyde) activity of the Ehrlich 
pathway to drive the flux towards phenylalanine rather than phenylacetaldehyde. A 
similar trend was also observed in the parent strain 22A, though the level of up-regulation 
was much less in all cases. In both mutant strains, meanwhile, almost no changes in 
transcription levels were observed for each of ARO4, ARO7, ARO9, and PHA2.  
 
Figure 4.4. Transcriptional analysis of top phenylalanine overproducing S. cerevisiae 
mutants. Relative transcript levels of the first round yeast mutant 22A and the second 
round yeast mutant 22A75D, normalized to their parental strain BY4741, for the genes 
ARO1 (black), ARO2 (right diagonal), ARO3 (dark gray), ARO4 (horizontal), ARO7 
(light gray), ARO8 (left diagonal), ARO9 (no fill), and PHA2 (hashed). Error bars 
reported at one standard deviation from triplicate experiments. 
 
The four up-regulated genes (ARO1, ARO2, ARO3, and ARO8) were further 
analyzed for their similarities in promoter sequences and transcriptional regulators. First, 
a common promoter sequence was investigated by aligning the sequences of 1000 bp 
prior to the start codon of the four genes. A possible consensus sequence was found to be 
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AACATC (located at ARO1,-292; ARO2,-307; ARO3, -289; ARO8,-290) though this 
sequence does not match any known transcription binding sequences. Next, common 
regulators of the four genes were determined from known regulators listed in the Yeast 
Genome Database and listed in Table 4.2. Eleven transcriptional regulators were found to 
be in common of these four up-regulated genes, but sequencing will be necessary to 
determine if any of these regulators are responsible for the increase in transcription level. 
 
Table 4.2. Common regulators of ARO1, ARO2, ARO3, and ARO8 
Regulator 
Association 
Type 
Description Reference 
ACE2 Negative Transcription factor required for septum 
destruction after cytokinesis; phosphorylation by 
Cbk1p blocks nuclear exit during M/G1 transition, 
causing localization to daughter cell nuclei, and 
also increases Ace2p activity; phosphorylation by 
Cdc28p and Pho85p prevents nuclear import 
during cell cycle phases other than cytokinesis; 
part of RAM network that regulates cellular 
polarity and morphogenesis; ACE2 has a paralog, 
SWI5, that arose from the whole genome 
duplication 
(Di Talia et al. 
2009) 
BAS1  Myb-related transcription factor; involved in 
regulating basal and induced expression of genes 
of the purine and histidine biosynthesis pathways; 
also involved in regulation of meiotic 
recombination at specific genes 
(Venters et al. 
2011) 
GCN4 Positive bZIP transcriptional activator of amino acid 
biosynthetic genes; activator responds to amino 
acid starvation; expression is tightly regulated at 
both the transcriptional and translational levels 
(Moxley et al. 
2009) 
(Natarajan et al. 
2001) 
(Uluisik et al. 
2011) 
 
LEU3 Negative Zinc-knuckle transcription factor, repressor and 
activator; regulates genes involved in branched 
chain amino acid biosynthesis and ammonia 
assimilation; acts as a repressor in leucine-replete 
conditions and as an activator in the presence of 
alpha-isopropylmalate, an intermediate in leucine 
biosynthesis that accumulates during leucine 
starvation 
 
(Boer et al. 2005) 
(Venters et al. 
2011) 
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Regulator 
Assoc. 
Type 
Description Reference 
 
RAD3 
  
5' to 3' DNA helicase; involved in nucleotide 
excision repair and transcription; subunit of RNA 
polII initiation factor TFIIH and of Nucleotide 
Excision Repair Factor 3 (NEF3); homolog of 
human XPD protein; mutant has aneuploidy 
tolerance; protein abundance increases in response 
to DNA replication stress 
 
(Venters et al. 
2011) 
SOK2 Positive Nuclear protein that negatively regulates 
pseudohyphal differentiation; plays a regulatory 
role in the cyclic AMP (cAMP)-dependent protein 
kinase (PKA) signal transduction pathway; 
relocalizes to the cytosol in response to hypoxia; 
SOK2 has a paralog, PHD1, that arose from the 
whole genome duplication 
(Rossouw, 
Jacobson, and 
Bauer 2012) 
(Vachova et al. 
2004) 
SSL1  Subunit of the core form of RNA polymerase 
transcription factor TFIIH; has both protein kinase 
and DNA-dependent ATPase/helicase activities; 
essential for transcription and nucleotide excision 
repair; interacts with Tfb4p 
(Venters et al. 
2011) 
SWI3  Subunit of the SWI/SNF chromatin remodeling 
complex; SWI/SNF regulates transcription by 
remodeling chromosomes; contains SANT 
domain that is required for SWI/SNF assembly; is 
essential for displacement of histone H2A-H2B 
dimers during ATP-dependent remodeling; 
required for transcription of many genes, 
including ADH1, ADH2, GAL1, HO, INO1 and 
SUC2; relocates to the cytosol under hypoxic 
conditions 
(Venters et al. 
2011) 
TAF1  TFIID subunit, involved in RNA pol II 
transcription initiation; possesses in vitro histone 
acetyltransferase activity but its role in vivo 
appears to be minor; involved in promoter binding 
and G1/S progression; relocalizes to the cytosol in 
response to hypoxia 
(Venters et al. 
2011) 
VPS72  Htz1p-binding component of the SWR1 complex; 
exchanges histone variant H2AZ (Htz1p) for 
chromatin-bound histone H2A; may function as a 
lock that prevents removal of H2AZ from 
nucleosomes; required for vacuolar protein sorting 
(Venters et al. 
2011) 
YRM1  Zinc finger transcription factor involved in 
multidrug resistance; Zn(2)-Cys(6) zinc finger 
transcription factor; activates genes involved in 
multidrug resistance; paralog of Yrr1p, acting on 
an overlapping set of target genes 
(Lucau-Danila et 
al. 2003) 
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While this level of analysis offers some clues as to changes associated with the 
evolved trait, elucidating the entire picture will likely only be possible through whole-
genome sequencing. However, given that the achievable phenylalanine titers are still 
quite modest (only up to ~350 mg/L), such an undertaking does not seem warranted at 
this time. For now, however, and for the purpose of this study, a phenylalanine over-
producing host has been developed that can now serve as a test platform for engineering 
styrene biosynthesis.  
4.3.3 Investigating native FDC1 activity and factors influencing its expression  
 The fact that FDC1 – the second enzyme in the established styrene pathway (Fig. 
4.1) – is native to S. cerevisiae was an important factor motivating its selection as a 
potential host platform for styrene biosynthesis. However, as factors controlling its native 
regulation have not yet been fully resolved, it was initially unclear if: i) background 
expression of FDC1 would occur in the specific strain and under the culture conditions of 
interest, or ii) expression levels would be sufficient for supporting ample flux through the 
last step of the pathway. With regards to the first point, it has previously been shown that 
PAD1 expression was induced in the presence of ferulic acid, coumaric acid, and trans-
cinnamate, when said species were added to growing cultures(Larsson, Nilvebrant, and 
Jonsson 2001). The potential role of trans-cinnamate (a styrene pathway intermediate and 
known substrate of FDC1) as an inducer of FDC1 expression, however, was not tested 
and has not before been reported. Thus, to better understand native expression of FDC1, 
particularly within the context of the styrene pathway, an investigation of factors 
influencing its induction was performed.  
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 Potential inducers of interest included both phenylalanine and trans-cinnamate, as 
well as coumaric acid and ferulic acid as both structural homologs to trans-cinnamate. 
BY4741 was cultured in minimal media supplemented with 200 mg/L of each species for 
12 h before collecting the cells by pelleting and preparing crude cell lysate. Cellular 
extracts were then each tested for in vitro decarboxylase activity on trans-cinnamate, as 
measured spectrophotometrically. As seen in Table 4.3, a positive result was observed for 
cells cultured in the presence of each of ferulic acid, trans-cinnamate, or coumaric acid, 
indicating that all three are suitable inducers of FDC1 expression. Interestingly, lysates 
prepared from cells grown in the presence of trans-cinnamate displayed the greatest 
specific trans-cinnamate decarboxylase activity. In contrast, phenylalanine was not an 
inducer of FDC1, nor was FDC1 activity detected in the control. This implies that FDC1 
expression is not constitutive. Furthermore, its expression in the final strain will be 
contingent upon PAL2 expression, which could be of benefit with respect to minimizing 
metabolic burden.  Further experiments, however, are certainly necessary before the 
mechanism of transcription initiation can be fully understood.  
Table 4.3. Assaying the in vitro decarboxylase activity of FDC1 against a pool of 
structurally-related, phenylacrylic acid substrates. 
Compound Induced activity mU/mg total protein 
trans-cinnamic acid Positive 0.46±0.02 
p-coumaric acid Positive 0.39±0.02 
ferulic acid Positive 0.21±0.03 
phenylalanine Negative Not Detected 
control Negative  Not Detected  
 
4.3.4 Probing the styrene pathway via the exogenous addition of phenylalanine  
Preliminary studies were next performed to begin probing the functionality of the 
styrene pathway, with the particular objectives of determining: i) if styrene can be 
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produced from exogenously supplied phenylalanine, and ii) if native expression levels of 
FDC1 are sufficient for supporting flux through the pathway. To test this, S. cerevisiae 
BY4741 was first transformed with 425GPDPAL (a high copy (2μ) number, constitutive 
plasmid) to enable the heterologous expression of PAL2 from A. thaliana. Cultures 
grown in SD-Leu minimal media were then supplied phenylalanine (200 mg/L) while the 
extracellular accumulation of key pathway metabolites trans-cinnamate and styrene, as 
well as the natural degradation product 2-phenylethanol, were monitored via HPLC for a 
period of 24 h. In BY4741, although only less than half of the phenylalanine was 
consumed, as shown in Fig. 4.5, styrene and 2-phenylethanol constituted the major 
accumulated end-products (20.4±0.8 and 43±0.45 mg/L, respectively). Importantly, no 
trans-cinnamate was detected in the culture medium at any time. This finding suggested 
that sufficient FDC1 activity was present so as to swiftly convert all trans-cinnamate to 
styrene as it was produced (i.e., implying that native levels of FDC1 expression are 
sufficient for circumventing the creation of a flux bottleneck).  
However, the question still remained as to whether the reason for not detecting 
trans-cinnamate in the culture medium was alternatively due to its potential inability to 
be exported by the cells. Whereas it has previously been shown that trans-cinnamate can 
be imported by S. cerevisiae (Mukai et al. 2010), its natural ability to be exported has 
never been explicitly reported. To test this, the control strain BY4741ΔFDC1 was 
similarly transformed with 425GPDPAL and analogously assayed. In this case, as seen in 
Fig. 4.5, 2-phenylethanol was the major product (98±2.98 mg/L) and no styrene 
production was observed. More importantly, however, in this case extracellular 
accumulation of trans-cinnamate (26.2±1.6 mg/L) was in fact observed, implying that it 
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is in fact naturally exported by S. cerevisiae. Thus, taken together, this study suggests that 
native FDC1 expression should in fact be sufficient for supporting flux through the 
styrene pathway, at the very least under the specific PAL2 expression levels considered.    
 Furthermore, in the absence of FDC1 to drive flux from phenylalanine through 
trans-cinnamate to styrene, a higher accumulation of phenylethanol was observed. This 
demonstrates that even though PAL2 is being constitutively expressed on a high copy 
number plasmid, it is insufficient for competing with the reverse reaction of ARO8 which 
degrades excess phenylalanine to phenylpyruvate and subsequently phenylethanol via the 
Ehrlich pathway. These results demonstrate the necessity for deletion of the Ehrlich 
pathway in order to drive flux through the styrene pathway.   
 
Figure 4.5. Assessing the trans-membrane export of trans-cinnamate. Phenylalanine 
(200 mg/L) fed to cultures of wild type S. cerevisiae BY4741 and BY4741 ΔFDC1. 
Results are shown at 48h for phenylalanine (black), trans-cinnamate (diagonal), styrene 
(horizontal), and 2-phenylethanol (gray). Error bars reported at one standard deviation 
from triplicate experiments. 
4.3.5 Styrene production from glucose 
Having demonstrated both the development of phenylalanine over-producing S. 
cerevisiae as well as the functionality of the styrene pathway enzymes in said host, the 
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final objective of this study was to demonstrate that styrene could by produced directly 
from glucose by S. cerevisiae. When the plasmid 425GPDPAL was transformed into 
BY4741 (strain BY4741-PAL) and cultured for 48 h in SD-Leu media for production of 
styrene, minimal amounts (less than 5 mg/L, Fig. 4.6) of styrene were detected. This was 
not unexpected since the concentration of phenylalanine was minimal in BY4741. Once 
the plasmid 425GPDPAL was transformed into the phenylalanine overproducer 22A75D 
(to generate strain 22A75D-PAL) and cultured for styrene production, styrene 
biosynthesis levels increased to 18.2±1.5 mg/L with 54.4±4.6 mg/L co-production of 
phenylethanol. The co-production of phenylethanol demonstrates that even though PAL 
is being over-expressed, it cannot compete with native metabolism and the natural 
regulation of phenylalanine production. In S. cerevisiae, the production of phenylalanine 
is not only regulated via feedback-inhibition but also via the Ehrlich pathway which 
converts the phenylalanine to phenylpyruvate in order to utilize the nitrogen from the 
amino acid (Hazelwood et al. 2008; Dickinson, Salgado, and Hewlins 2003). At this 
point, further strain improvements were necessary to increase styrene titers.  
Due to the endogenous Ehrlich pathway present in yeast, phenylpyruvate is 
subsequently converted to phenylacetaldehyde and phenylethanol rather than styrene by 
means of ARO10(Caspi et al. 2006; Hazelwood et al. 2008). To prevent degradation of 
phenylpyruvate, ARO10 was subsequently deleted from strain 22A75D to create strain 
22A75D10. The ARO10 knockout strain hosting the 425GPDPAL plasmid, strain 
22A75D10-PAL, had a modest improvement in styrene synthesis achieving a final titer of 
22.7±1.9 mg/L. Since trans-cinnamate was not observed in the culture media, it was 
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believed that the styrene titers suffered from a lack of precursor availability, and to 
improve titers, an increase in phenylalanine was needed.   
 To enhance flux through the phenylalanine pathway, it has been previously 
reported that the tyrosine sensitive DAHP synthase mutant ARO4
K229L
 alleviates 
feedback inhibition from tyrosine and can increase flux through the shikimic acid 
pathway by as much as 4.5 fold(Curran et al. 2013; Luttik et al. 2008). In an attempt to 
relieve the feed-back regulation, we incorporated the tyrosine-sensitive feedback resistant 
DAHP synthase mutant ARO4
K229L
 onto the genome while simultaneously deleting 
ARO10. The strain 22A75D104 was then transformed with the plasmid 425GPDPAL to 
achieve the strain 22A75D104-PAL (expressing both ARO4
K229L
 and PAL2). 
22A75D104-PAL achieved a 25% increase (Fig. 4.6) in styrene production to 28.8±2.1 
mg/L with a glucose yield of 0.00144±0.00011 g/g. It is important to note, however, that 
ARO4 is feed-back sensitive to tyrosine (not phenylalanine) (Caspi et al. 2006); 
therefore, it is not surprising that it did not have a more impactful result. To date, a 
feedback-resistant mutant of the phenylalanine sensitive DAHP synthase homolog ARO3 
has not been discovered. While this point-mutation demonstrates a modest increase in 
flux through the shikimic acid pathway, achievable phenylalanine yields are still quite 
low in yeast suggesting that the pathway is tightly regulated beyond the DAHP synthase. 
In order for higher titers to be realized, further de-regulation of the phenylalanine 
biosynthesis pathway in S. cerevisiae must be achieved. 
 With only a modest improvement from its predecessor, we believe that the 
bottleneck is a result of poor PAL activity. Although flux through the phenylalanine 
pathway greatly improved in mutant 22A75D, we believe that the activity of PAL is not 
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sufficient enough to draw flux through the styrene pathway. The poor activity of PAL is 
further supported by the fact that during the fermentation, no trans-cinnamate is detected 
in the supernatant. As a result of the low PAL activity, we believe that phenylalanine 
accumulates within the cell (recall phenylalanine cannot be exported) and subsequently 
imposes further feedback regulation upon the pathway. Furthermore, since PAL activity 
is low, it most likely cannot compete with the reverse reaction of ARO8 and ARO9 for 
phenylalanine, and thus phenylalanine undergoes the transamination reaction freeing the 
nitrogen for use elsewhere within the cell. 
 
 
Figure 4.6. Styrene biosynthesis from glucose by engineered S. cerevisiae. Styrene 
concentration for the strains BY4741-PAL, 22A75D-PAL, 22A75D10-PAL, and 
22A75D104-PAL after 48 h in shake flasks. Error bars reported at one standard deviation 
from triplicate experiments. 
4.4 Conclusion 
 Unlike E. coli, for which a phenylalanine overproducer capable of producing 
phenylalanine in excess of 1 g/L has already been engineered(McKenna and Nielsen 
2011; Tribe 1987), little work has been done previously to generate a robust 
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phenylalanine overproducer in S. cerevisiae. Through systematic strain and pathway 
engineering, the biosynthetic production of styrene from glucose by S. cerevisiae has 
been demonstrated for the first time. Although limited PAL activity as well as precursor 
availability of the pathway precursor phenylalanine limits the overall productivity and 
remains a challenge, continued improvements on engineering a more robust 
phenylalanine overproducer as well as enhancing PAL activity will lead to greater yields 
and a more sustainable approach for styrene biosynthesis.     
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CHAPTER 5 
DISCUSSION AND FUTURE WORK 
Abstract 
The styrene pathway has successfully been engineered in both E. coli and S. 
cerevisiae. Furthermore, the styrene pathway has been extended for production of the 
styrene derivatives (S)-styrene oxide and (R)-1,2-phenylethanediol in engineered E. coli. 
Currently, however, product toxicity, poor precursor availability, and poor PAL activity 
remain a challenge. This chapter discusses those weaknesses of the current processes and 
suggests potential future directions.  
5.1 Introduction 
These works have demonstrated the possibility of using microorganisms for the 
production of styrene, a plastics monomer commercially produced from petroleum 
derivatives. This renewable approach has created a ‘green’ process for not only styrene 
but has also opened the door for the biosynthetic production of the styrene derivatives 
(S)-styrene oxide and (R)-1,2-phenylethanediol by extension of the styrene pathway. In 
our endeavors to maximize both titers and yields of styrene and its derivatives, we have 
pushed the boundaries of our E. coli host and are limited by product toxicity and/or 
precursor availability. Though we have demonstrated that the yeast S. cerevisiae may be 
a more robust, solvent tolerant host, precursor availability remains a limiting factor. Thus, 
in order to further improve upon the achievable titers and yields as well as establish a 
robust, economical process for styrene production we must continue to explore routes for 
94 
 
process improvements, including i) relieving or circumventing product toxicity, ii) 
enhancing precursor availability, and iii) improving recombinant PAL activity.    
5.2 In situ product removal as a method to overcome toxicity 
 Due to the hydrophobic nature of styrene and its derivatives, it is believed that 
product accumulation occurs within the lipid bi-layer of the cell membrane resulting in 
reduced membrane fluidity and integrity. According to the model of Sikkema et al., there 
exists a linear relationship between a compounds hydrophobicity, as measured by its 
octanol-water partition coefficient (log KOW), and its propensity to accumulate in the 
membrane lipid bi-layer of an organism, as measured by the membrane-water partition 
coefficient (log KMW)(Sikkema, de Bont, and Poolman 1994). In order to understand the 
toxic effects of a particular solvent, we have previously demonstrated that the toxicity 
limit may be estimated by adding the compound directly to the culture medium and 
monitoring the growth response. When the concentration of a product reaches a threshold 
at which the cells can no longer proliferate, we designate this threshold as the toxicity 
limit. When we compared the toxicity limit of styrene and its derivatives with their 
predicted membrane-water partition coefficient (KM/W), we found that there was a strong 
linear correlation (Fig 3.2) providing further evidence to support the hypothesis that the 
intra-membrane accumulation of hydrophobic entities is the cause of reduced host fitness.  
Table 5.1: Toxicity Limit Analysis of Styrene and its Derivatives  
Product  
(Log KOW) 
Host Highest Titer 
Maximum 
Toxicity 
Threshold 
% of Toxicity 
Limit 
Achieved 
Styrene 
(3.05) 
E. coli 260 ± 4.3mg/L 300 mg/L 87% 
S. cerevisiae 28.8 ± 2.1 mg/L 600 mg/L 5% 
(S)-Styrene Oxide 
(1.61) 
E. coli 1.32 ± 0.03 g/L 1.6 g/L 83% 
(R)-1,2-Phenylethanediol 
(0.92) 
E. coli 1.23 ± 0.07 g/L 8 g/L 15% 
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 Product toxicity remains the greatest hindrance in achieving a high titer 
biosynthetic process for styrene production. In E. coli, styrene titers are currently limited 
to 260±4.3 mg/L, approximately 87% of the estimated toxicity limit of ~300 mg/L. It is 
important to note however, that it is unlikely that a product could ever truly reach the 
toxicity limit, rather in actuality, there must exist a balance between host fitness and the 
metabolic burden associated with expressing a heterologous pathway. Similar to styrene, 
the (S)-styrene oxide titers also approach the toxicity limit achieving 1.32 ± 0.03 g/L, 
approximately 83% of the estimated toxicity limit of 1.6 g/L. In the case of (S)-styrene 
oxide however, precursor availability of phenylalanine was also a limiting factor. In an 
attempt to overcome our toxicity obstacle, a new host, S. cerevisiae, was evaluated for its 
potential to produce styrene. Though the toxicity limit of S. cerevisiae was twice higher 
(~600 mg/L), other factors including poor precursor availability and low PAL activity 
limited the final titer to 28.8 mg/L, 5% of the toxicity limit. While finding a more 
solvent-tolerant host and improving its ability to produce styrene remains a goal, a more 
attractive option to addressing product toxicity may be in situ product removal (ISPR). 
Not only would ISPR circumvent the toxicity issue, it would also, by nature, 
recover the compound of interest. Some examples of ISPR approaches include liquid-
liquid extraction (or solvent extraction)(Gyamerah and Glover 1996; Malinowski 2001; 
Weilnhammer and Blass 1994), adsorption(Nielsen, Amarasiriwardena, and Prather 
2010; Nielsen and Prather 2009), gas and vacuum stripping(Loser et al. 2005), and 
membrane pervaporation(Vane 2005). These approaches have been successfully applied 
for the continuous recovery of many chemical compounds including ethanol as well as 
the aromatics L-phenylacetylcarbinol(Khan and Daugulis 2010) and benzaldehyde(Jain, 
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Khan, and Daugulis 2010). Although the hydrophobic and volatile nature of styrene 
proved to negatively limit titers due to the associated toxicity, these qualities conversely 
make styrene amenable to ISPR.  
Taking advantage of styrene’s volatility, we first attempted to utilize gas stripping 
coupled to a cold trap for retention of styrene in a bioreactor model. The outlet gas of the 
bioreactor was monitored for the concentration of stripped styrene by taking 100 µL gas 
samples from the effluent using a Hamilton gas tight syringe (Hamilton, Reno NV) for 
subsequent analysis by gas chromatography (GC). GC analysis of styrene gas was 
performed on a Hewlett Packard 5890 Series II gas chromatograph with a flame ionizing 
detector and Agilent DB-5 (30 m × 0.25 mm id) fused-silica capillary column using 
helium as the carrier gas. The injector, column, and detector temperatures were set at 250 
°C. 
The accumulated concentration of styrene that was produced by the culture after 
42 h was determined from the gas samples to be ~464 mg/L, refer to Fig. 5.1 for time 
course production of styrene. While gas stripping proved effective for removing styrene 
from the culture medium and increasing the yield by almost two-fold, our lab-scale cold-
trap was ill-equipped for retaining stripped styrene. Due to the quick rate of loss of 
styrene during gas stripping, other approaches such as solvent extraction (via overlays) or 
pervaporation are most likely the best option for styrene removal and recovery.  
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Figure 5.1. Styrene accumulation in bioreactor. The styrene effluent gas of the 
bioreactor was analyzed by GC for 42 h to determine the amount of styrene produced. 
 
Solvent extraction has been used successfully for the extraction of many 
microbial-derived products, most notably the terpene amorpha-4,11-diene, a precursor to 
the anti-malarial drug artemisinin. Similar to styrene, amorpha-4,11-diene is both 
hydrophobic and volatile. In experiments by Newman et al., it was found that amorpha-
4,11-diene evaporated at a half life of 50 min from the culture, but using an organic 
dodecane solvent overlay, researchers were able to improve retention of the product 
achieving titers of over 0.5 g/L cultures(Newman et al. 2006). Although dodecane is 
hydrophobic, it tends to not interact with the hydrophilic surface of the membrane lipid 
bi-layer making its contribution to toxicity minimal. Furthermore, its extremely low 
water solubility makes it useful for subsequent separation from the aqueous solution. To 
test the feasibility of solvent overlays for the ISPR of styrene, we evaluated the organic 
solvents dodecane, hexadecane, and bis(2-ethylhexyl) phthalate (BEHP). In our 
experiment, we used 10 mL of solvent per 50 mL of culture of our styrene producing 
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strain, E. coli NST74 harboring pSpal1At and pTfdc1Sc. As illustrated in Fig. 5.2, in the 
presence of hexadecane, styrene titers reached 436 mg styrene/L culture (2.18 g styrene/L 
hexadecane), a modest 1.7-fold improvement over the 260 mg/L produced with no 
solvent overlay. Cultures with dodecane overlays performed slightly better achieving 544 
mg styrene/L culture (2.72 g styrene/L dodecane), a 2-fold improvement. The highest 
titers however were achieved by utilizing BEHP as the overlay solvent, for which an 
impressive 836 mg styrene/L culture (4.18 g styrene/L BEHP) was produced. This 
represents a 3.2-fold improvement in styrene production and is the highest titer of styrene 
that has ever been achieved in E. coli. In order to reach higher titers, further strain 
improvements, in particular increased phenylalanine production, must be realized.  
 
Figure 5.2. In situ product removal of styrene via solvent extraction E.coli NST74 
harboring the styrene pathway plasmids pSpal1At and pTfdc1Sc was cultured in 50 mL 
MM1 media with 10 mL of solvent: hexadecane, dodecane, or (BEHP).   
 
5.3 Improving Precursor Availability 
Although it was demonstrated that the toxicity of styrene may be circumvented 
via ISPR, the availability of the precursor phenylalanine is also a limiting factor and 
needs to be further enhanced for titers to approach the theoretical yield. Several different 
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theoretical yields have been previously calculated from known stoichiometry of 
phenylalanine biosynthesis from glucose based on different metabolic scenarios(Baez-
Viveros et al. 2004; Takagi et al. 1996; Patnaik and Liao 1994; Förberg, Eliaeson, and 
Häggström 1988). In wild type E. coli, the phosphotransferase system (PTS) imports 
glucose and converts one mole of phosphoenolpyruvate (PEP) to one mole of pyruvate 
(PYR). If the competing aromatic amino acid pathways  for tyrosine and tryptophan are 
knocked out and there is no feed-back inhibition imposed upon the phenylalanine 
pathway, the maximum theoretical yield of phenylalanine is 0.275 g/g (assuming carbon 
dioxide is produced at a rate of 3.33 mol/mol glucose)(Förberg, Eliaeson, and Häggström 
1988). If, however, E. coli is engineered to recycle PYR to PEP, resulting in less carbon 
being lost as carbon dioxide (2.62 mol/mol glucose), the yield is increased to 0.34 g/g 
(Förberg, Eliaeson, and Häggström 1988). Recycling PYR requires the expression of the 
PEP synthetase (PpsA) which is not typically induced by growth on glucose. The 
maximum PYR able to be recycled was determined by the break point when the TCA 
(citric acid) cycle balanced NADPH. The maximum theoretical yield possible would be if 
all PYR is recycled to PEP or the PTS was inactivated resulting in a yield of 0.55 
g/g(Förberg, Eliaeson, and Häggström 1988). This theoretical yield is highly improbable 
to ever experimentally reach though since it assumes no carbon enters the TCA cycle 
which would severely hinder cell viability. Current experimental yields from this project 
have yet to reach the most probable theoretical yield of 0.275 g/g, though some strain 
improvements have proven effective in working toward that goal. 
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Table 5.2. Summary of titers and yields for styrene and its derivatives  
Product Host Highest Titer 
Max Yield 
(styrene/glucose) 
% of 
Theoretical 
Yield
1 
Styrene 
E. coli 
NST74 
260 ± 4.3mg/L, 
25.0 ± 0.04 mM 
0.03 ± 0.005 g/g,  
0.05 ± 0.009 mol/mol 
17% 
S. cerevisiae 
22A75D 
28.8 ± 2.1 mg/L, 
0.28 ± 0.02 mM 
0.0014 ± .0001 g/g 
0.0024 ± .0001 mol/mol 
- 
(S)-Styrene 
Oxide 
E. coli 
NST74ΔtyrA 
1.32 ± 0.03 g/L, 
11.0 ± 0.25 mM 
0.12 ± 0.005 g/g, 
0.17 ± 0.01 mol/mol 
60% 
(R)-1,2-
Phenylethanediol 
E. coli 
NST74ΔtyrA 
1.23 ± 0.07 g/L, 
8.9 ± 0.51 mM 
0.11 ± 0.002 g/g, 
0.14 ± 0.01 mol/mol 
47% 
1
 Assumes a maximum yield of 0.275 g-phenylalanine/g-glucose 
Through strain development, we have been able to achieve as high as 60% of the 
theoretical yield. In Chapter 3, it was shown that (S)-styrene oxide titers were raised in E. 
coli NST74 from 1.1 g/L to 1.32 g/L (resulting in a yield of 0.12 g/g, Table 5.2) by 
deleting the competing tyrosine pathway. While effective, the drawback of this approach 
is that tyrosine must now be supplemented to the culture medium. In addition to deleting 
the competing tyrosine pathway, it was also shown that enhancing the production of the 
phenylalanine precursor erythrose-4-phosphate, via overexpression of the transketolase 
tktA, had a significant impact on improving phenylalanine titers achieving ~1.55 g/L, a 
40% increase. However, when tktA was overexpressed in combination with the 
heterologous pathway, an improvement in product titers was not observed, presumable 
due to increased metabolic burden. Single gene mutations, deletions, or overexpression of 
pathway genes, in efforts to drive more flux through the pathway, are not only time 
consuming but often result in minimal yield improvements.    
In order to have a more global impact on the phenylalanine pathway, methods 
beyond single gene alterations needs to be considered. For example, other approaches 
may include media optimization or modifying the sugar transport system. For example, 
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lycopene titers were increased 7-fold in E. coli by i) removing the PTS to increase PEP 
availability, ii) feeding glycerol, a non-PTS sugar, and iii) optimizing media components 
via statistical design of experiments(Zhang et al. 2013). While modifying the PTS has 
shown to be effective in E.coli, yeast rely on facilitated diffusion for glucose import so 
conservation of PEP is not a concern(Lagunas 1993). 
As an alternative approach, procedures such as global Transcription Machinery 
Engineering (gTME)(Alper et al. 2006; Nicolaou, Gaida, and Papoutsakis 2010) may be 
implemented to increase phenylalanine titers as well as perhaps improve styrene 
tolerance in our hosts E. coli and S. cerevisiae. The principals of gTME have been 
successfully employed to enhance ethanol tolerance in both yeast(Alper et al. 2006) and 
E. coli (Alper and Stephanopoulos 2007). Furthermore, gTME was also applied in S. 
cerevisiae to increase ethanol tolerance through mutagenesis of the Spt15p transcription 
factor encoding the TATA-binding protein resulting in a 15% increase in ethanol 
yield(Alper et al. 2006). Furthermore, in E. coli gTME was used to mutate RpoD, 
encoding sigma factor σ70, to increase ethanol tolerance as well as increase lycopene 
production in parallel(Alper and Stephanopoulos 2007). In theory, gTME could be 
applied to RpoD as well as the sigma factor responsible stationary phase activity, σ38 
encoded by RpoS, in hope that phenylalanine titers would increase during both the 
exponential and  stationary phases (when synthesis is typically stagnant) given a high-
throughput selection method was used.  
Investigating strategies for yeast specifically, there are several strategies that can 
be made to the aromatic amino acid pathway in S. cerevisiae to further increase 
phenylalanine titers. First, the transketolase TKL1 may be overexpressed to increase 
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production of E-4P. This may be especially advantageous since TKL1 is believed to be 
feedback regulated by hydroxyphenylpyruvate, the precursor to tyrosine. Second, the 
glucose-6-phosphate dehydrogenase, ZWF1, may be knocked out to force entry into the 
pentose phosphate pathway via E-4P. When these two modifications were combined for 
muconic acid production, their synergistic effect resulted in a two-fold increase in titers 
(Curran et al. 2013). In addition to increasing E-4P precursor availability, further 
deregulation of the phenylalanine pathway would likely increase flux. For example, the 
tyrosine sensitive chorismate mutase ARO7 may be de-regulated via single point 
mutation ARO7
G141S
(Curran et al. 2013); however, this is likely to increase titers of both 
phenylalanine as well as tyrosine. 
It is possible based on the results of increasing phenylalanine in E. coli presented 
in Chapter 3 (Fig. 3.5) that deletion of TYR1 to create a tyrosine auxotroph may direct 
flux to phenylalanine. This approach has not yet been investigated in S. cerevisiae to 
enhance phenylalanine concentrations, but the TYR1 knockout is available from Thermo 
Scientific (Strain 852464). However, since this strategy would require supplementation of 
exogenous tyrosine to the culture media at relatively high concentrations, it is likely that 
tyrosine would impose feedback regulation upstream in the pathway. Alternatively, it 
may be more optimal to use a gene knock-down approach which has been previously 
shown to be possible in yeast with as little as 21 bp hairpin structured and silence genes 
through translational repression which has been shown to be capable of reducing activity 
up to 60%(Elbashir, Lendeckel, and Tuschl 2001; McManus et al. 2002).  
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5.4 Improving PAL Activity 
 PAL activity was shown to be the rate limiting step for the styrene pathway in 
both hosts, E. coli and S. cerevisiae. Strategies to improve enzyme expression include 
tuning the ribosomal binding site (RBS) and translation initiation region, using a stronger 
promoter (such as trc or T7), increasing the copy number of the protein expression 
system, changing the transcriptional promoter (constitutive versus inducible), or changing 
the concentration of the inducer. Previous attempts at improving PAL activity in E. coli 
involved using a stronger promoter (trc versus lac) and a plasmid with a higher copy 
number (20 verses 10 copies/cell); although, this resulted in minimal increase of activity 
(data not shown). With the exception of tuning the RBS, the aforementioned strategies 
specifically address transcriptional improvements, as opposed to translational 
improvements. One of the key problems associated with expressing heterologous 
enzymes in engineered hosts is that the codon usage is foreign and generally not optimal 
for high level expression. Not only could improper codon usage create a potential 
bottleneck, it may also unnecessarily increase the metabolic burden on the host. As a 
result of the redundancy of the genetic code, each organism demonstrates preferences for 
certain codon usage which is dependent on the relative abundance and diversity of tRNA 
within the host(Jana and Deb 2005). Codon optimization offers the chance to alter the 
codon usage of a protein without altering the protein's sequence. Not only can codon 
optimization tune the tRNA usage and improve protein translation, it can also be used to 
optimize the GC content as well as remove unwanted RNA secondary 
structures(Gustafsson, Govindarajan, and Minshull 2004; Wu et al. 2004). Codon 
optimization has proven useful for increasing product titers, for example mevalonate in E. 
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coli(Anthony et al. 2009) and muconic acid in S. cerevisiae(Curran et al. 2013). While 
PAL activity remains an obstacle, particularly in S. cerevisiae, codon optimization, as 
well as other previously mentioned techniques, may prove effective in improving titers.        
While the previously suggested enzyme activity improvement techniques rely on 
improving PAL2 from A. thaliana, it is possible that this specific isoenzyme may not 
have the highest activity in all hosts. While it was previously demonstrated that PAL2 
had the highest recombinant activity in E. coli, the pool of candidate enzymes was small 
consisting of only four isozymes (Chapter 2). In future works, it is suggested that 
alternative PAL isoenzymes be tested for their possible greater PAL activity. Examples 
of other PAL plant sources include Nicotiana tabacum(O'Neal and Keller 1970; 
Fukasawa-Akada, Kung, and Watson 1996), Bambusa oldhamii(Hsieh et al. 2011; Hsieh 
et al. 2010), Lycoris radiata(Jiang et al. 2011), Salvia Miltiorrhiza(HU et al. 2009), 
Cynara cardunculus(De Paolis et al. 2008; Pandino et al. 2011), and Daucus carota(De 
Lorenzo et al. 1987), to name a few. 
5.5 Conclusion 
 These works constitute a 'proof of concept' that it is possible to engineer 
microorganisms with the pathways necessary to replace chemical products of 
petrochemical origin with those biosynthesized from renewable resources. Though these 
processes are not currently at an economical scale, there is immense opportunity for 
future improvement. Through in situ product removal, enhanced precursor availability, 
and increased enzyme activity there is potential for increased titers that may one day be 
able to compete with the petroleum industry.  
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